| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | -- | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.1.8 | Sevoflurane Inhalation | Abbott India Limi | -- | Sevoflurane Liquid | -- | 250 | ml | 6350.00 | 90100000 | 68.16% | 25.40 | -- |
| -- | 1.1.8 | Sevoflurane Inhalation | Piramal Healthca | -- | Sevoflurane Inhala | -- | 250 | ml | 6250.00 | 36650000 | 27.73% | 25.00 | -- |
| -- | 1.1.8 | Sevoflurane Inhalation | Baxter | -- | Sevoflurane Inhala | -- | 250 | ml | 5500.00 | 5434000 | 4.11% | 22.00 | -- |
|
-- |
-- | 132184000 | 100.00% | 24.13 | 27.99 | ||||||||
|
-- |
-- | Maximum | 25.40 | Minimum | 22.00 | ||||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | ||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
1321.84 | (Rs. In Lakhs) | -- | -- | -- | ||||||
|
-- |
Sum of PTR per unit considered for price calculation | -- | -- | -- | -- | 72.40 | -- | -- | -- | -- | |||
|
-- |
Number of Packs considered | -- | -- | -- | -- | -- | 3 | -- | -- | -- | -- | ||
|
-- |
Ceiling Price | -- | -- | -- | -- | -- | -- | 24.13 | -- | -- | -- | -- | |
|
-- |
Add : 16% Retailer Margin | -- | -- | -- | -- | -- | -- | 3.86 | -- | -- | -- | -- | |
|
-- |
MRP (without local taxes) | -- | -- | -- | -- | -- | -- | 27.99 | -- | -- | -- | -- | |
|
-- |
% Reduction with compared to Highest Price | -- | -- | -- | -- | -- | 4.99% | -- | -- | -- | -- | ||
|
-- |
-- |
-- | -- | -- | -- | -- | S.O. 2850(E) dated 20.09.13 | -- | -- | -- | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 1.2.1.1 | Bupivacaine Hydrochloride Inje | ASTRAZENECA | SENSORCAIN | SENSORCAINE I | Vials | 20 | ML | 40.80 | 450080 | 2.48% | 2.04 | -- |
| -- | 1.2.1.1 | Bupivacaine Hydrochloride Inje | Neon Labs | ANAWIN | SENSORCAINE I | Vials | 20 | ML | 39.00 | 17722000 | 97.52% | 1.95 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
-- |
-- | 18172080 | 100.00% | 1.99 | 2.31 | ||||||||
|
-- |
-- | Maximum | 2.04 | Minimum | 1.95 | ||||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | ||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
181.72 | (Rs. In Lakhs) | -- | -- | -- | ||||||
|
-- |
Sum of PTR per unit considered for price calculation | -- | -- | -- | -- | 3.99 | -- | -- | -- | -- | |||
|
-- |
Number of Packs considered | -- | -- | -- | -- | -- | 2 | -- | -- | -- | -- | ||
|
-- |
Ceiling Price | -- | -- | -- | -- | -- | -- | 1.99 | -- | -- | -- | -- | |
|
-- |
Add : 16% Retailer Margin | -- | -- | -- | -- | -- | -- | 0.32 | -- | -- | -- | -- | |
|
-- |
MRP (without local taxes) | -- | -- | -- | -- | -- | -- | 2.31 | -- | -- | -- | -- | |
|
-- |
% Reduction with compared to Highest Price | -- | -- | -- | -- | -- | 2.20% | -- | -- | -- | -- | ||
|
-- |
-- |
-- | -- | -- | -- | -- | S.O. 2851(E) dated 20.09.13 | -- | -- | -- | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 1.2.1.2 | Bupivacaine Hydrochloride Inje | ASTRAZENECA | SENSORCAIN | SENSORCAINE I | Vials | 20 | ML | 65.72 | 2918298 | 7.60% | 3.29 | -- |
| -- | 1.2.1.2 | Bupivacaine Hydrochloride Inje | Neon Labs | ANAWIN | SENSORCAINE I | Vials | 20 | ML | 53.00 | 32364000 | 84.34% | 2.65 | -- |
| -- | 1.2.1.2 | Bupivacaine Hydrochloride Inje | TROIKAA PHAR | BUPITROY | BUPITROY INJ VI | Vials | 20 | ML | 61.98 | 2912000 | 7.59% | 3.10 | -- |
| -- | 1.2.1.2 | Bupivacaine Hydrochloride Inje | ALKEM* | BUPIDURAL | BUPIDURAL INJ | Vials | 20 | ML | 61.00 | 180107 | 0.47% | 3.05 | -- |
| -- | -- |
-- |
-- | 38374405 | 100.00% | 3.01 | 3.49 | ||||||
| -- | -- |
-- |
-- |
Maximum | 3.29 | Minimum | 2.65 | ||||||
| -- | -- | Sum of MAT value considered for price calculatio | 381.94 | -- | (Rs. In Lak |
-- |
-- |
||||||
| -- | -- | Sum of PTR per unit considered for price calculat | 9.04 |
-- |
-- |
-- |
|||||||
| -- | -- | Number of Packs considered | -- | 3 |
-- |
-- |
-- |
||||||
| -- | -- | Ceiling Price | -- | 3.01 |
-- |
-- |
-- |
||||||
| -- | -- | Add : 16% Retailer Margin | -- | 0.48 |
-- |
-- |
-- |
||||||
| -- | -- | MRP (without local taxes) | -- | 3.49 |
-- |
-- |
-- |
||||||
| -- | -- | % Reduction with compared to Highest Price | 8.35% |
-- |
-- |
-- |
|||||||
| -- | -- |
-- |
S.O. 2852(E) d |
-- |
-- |
-- |
|||||||
| -- | -- |
-- |
-- |
-- |
-- |
-- |
|||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ML | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 1.2.1.3 | Bupivacaine HCL Inj 0.5% with | Neon Laboratorie | Anawin heavy(S | Bupivacaine Hydro | Amp | 1X4ml | 19.00 | 84233000 | 92.16% | 4.75 | -- |
| -- | 1.2.1.3 | Bupivacaine HCL Inj 0.5% with | TROIKAA PHAR | BUPITROY He | BUPITROY INJ H | Vials | 5X4ml | 98.45 | 3987000 | 4.36% | 4.92 | -- |
| -- | 1.2.1.3 | Bupivacaine HCL Inj 0.5% with | AstraZenaca | Sensocaine 0.5 | Bupivacaine HCL Inj 0.5% with 7.5% Glucose ( 10×4) | Amp | 10X4ml | 206.26 | 3176135 | 3.48% | 5.16 | -- |
|
-- |
-- | 91396135 | 100.00% | 4.94 | 5.73 | |||||||
|
-- |
-- | Maximum | 5.16 | Minimum | 4.75 | |||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | ||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
913.96 | (Rs. In Lakhs) | -- | -- | -- | |||||
|
-- |
Sum of PTR per unit considered for price calculation | -- | -- | -- | 14.83 | -- | -- | -- | -- | |||
|
-- |
Number of Packs considered | -- | -- | -- | -- | 3 | -- | -- | -- | -- | ||
|
-- |
Ceiling Price | -- | -- | -- | -- | -- | 4.94 | -- | -- | -- | -- | |
|
-- |
Add : 16% Retailer Margin | -- | -- | -- | -- | -- | 0.79 | -- | -- | -- | -- | |
|
-- |
MRP (without local taxes) | -- | -- | -- | -- | -- | 5.73 | -- | -- | -- | -- | |
|
-- |
% Reduction with compared to Highest Price | -- | -- | -- | -- | 4.14% | -- | -- | -- | -- | ||
|
-- |
-- |
-- | -- | -- | -- | S.O. 2853(E) dated 20.09.13 | -- | -- | -- | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | Price per unit | MAT Value as on 31st May 2012 | MAT % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 1.2.2.1 | Lignocaine Hydrochloride Topic | ASTRAZENECA | XYLOCAINE | XYLOCAINE JEL | XYLOCAI | Jelly | 30 | G | 41.98 | 1.40 | 12729180 | 16.04% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | ASTRAZENECA | XYLOCAINE | XYLOCAINE LIQ | XYLOCAI | Liquid (Bottle) | 100 | ML | 29.10 | 0.29 | 1024706 | 1.29% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | ASTRAZENECA | XYLOCAINE | XYLOCAINE 5% | XYLOCAI | Ointment | 20 | G | 34.54 | 1.73 | 1790001 | 2.26% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | NEON LABS | LOX | LOX JELLY 2 % 3 | LOX JELL | Gels/SOLs | 30 | G | 32.00 | 1.07 | 51463915 | 64.86% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | NEON LABS | LOX | LOX SOLUT. 4 % | LOX SOL | Topical Liquid | 30 | ML | 21.00 | 0.70 | 2116508 | 2.67% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | TROIKAA PHAR | XYNOVA | XYNOVA GEL 2 | XYNOVA | Gels/SOLs | 30 | G | 40.84 | 1.36 | 6567000 | 8.28% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | WOCKHARDT L | WOCAINE | WOCAINE MOUT | WOCAINE | Gels/SOLs | 30 | g | 16.72 | 0.56 | 2202718 | 2.78% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | CADILA PHARM | LIGNOCAD | LIGNOCAD GEL | LIGNOCA | Gels/SOLs | 30 | G | 14.42 | 0.48 | 780423 | 0.98% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | INDOCO* | LIGNOX | LIGNOX GEL 2 % | LIGNOX G | Gels/SOLs | 30 | G | 17.60 | 0.59 | 671615 | 0.85% |
| -- | 1.2.2.1 | Lignocaine Hydrochloride Topic | ABBOTT* | GESICAIN | GESICAIN JELLY | GESICAIN | Gels/SOLs | 30 | ML | 15.16 | 0.51 | 1046 | 0.00% |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.01 | 79347112 | 100.00% |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 1.73 | minimum | 0.29 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Sum of MAT value considere | 778.94 | (Rs. In Lakhs) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Sum of PTR per unit conside | 7.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Number of Packs considered | 7 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Ceiling Price | 1.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | 0.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | MRP (without local taxes) | 1.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
-- |
% Reduction as compared to | 41.24% |
-- |
||||||||||
|
-- |
-- | S.O. 2854(E) dated 20.09.13 |
-- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | --
|
Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ML | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 1.2.3.2 | Lignocaine Hydrochloride +Adr | Modern Laborato |
-- |
(2% + 1 mg)/ml | Vial | 30 | ml | 7.77 | 239297 | 60.09% | 0.26 |
-- |
|
-- |
1.2.3.2 | Lignocaine Hydrochloride +Adr | Nirma |
-- |
-- |
Vial | 30 | ml | 21.67 | 158907 | 39.91% | 0.72 |
-- |
|
-- |
1.2.3.2 | Lignocaine Hydrochloride +Adr | ICPA | XICAINE 2000 | XICAINE 200000 | Vial | 30 | ml | 20.79 | 0 | 0.00% | 0.69 |
-- |
|
-- |
-- |
398204 | 100.00% | 0.49 | 0.57 | ||||||||
|
-- |
-- |
Maximum | 0.72 | Minimum | 0.26 | ||||||||
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
3.98 | (Rs. In Lakhs) |
-- |
-- |
-- |
||||||
|
-- |
Sum of PTR per unit considered for price calculation |
-- |
-- |
-- |
-- |
0.98 |
-- |
-- |
-- |
-- |
|||
|
-- |
Number of Packs considered |
-- |
-- |
-- |
-- |
-- |
2 |
-- |
-- |
-- |
-- |
||
|
-- |
Ceiling Price |
-- |
-- |
-- |
-- |
-- |
-- |
0.49 |
-- |
-- |
-- |
-- |
|
|
-- |
Add : 16% Retailer Margin |
-- |
-- |
-- |
-- |
-- |
-- |
0.08 |
-- |
-- |
-- |
-- |
|
|
-- |
MRP (without local taxes) |
-- |
-- |
-- |
-- |
-- |
-- |
0.57 |
-- |
-- |
-- |
-- |
|
|
-- |
% Reduction with compared to Highest Price |
-- |
-- |
-- |
-- |
-- |
32.07% |
-- |
-- |
-- |
-- |
||
|
-- |
S.O. 2855(E) dated 20.09.13 |
-- |
|||||||||||
| Note- Mat Value not given by ICPA because product manufacture from may 2012 | |||||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Injection/Ampoule | Ceiling Price with 16% Margin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 2.2.1 & 1.3. | Morphine Sulphate Injection 10 | Verve Health Car | Vermor | Morphine Sulphate | Injection | 1 | Ampoul | 17.50 | 1073134 | 55.28% | 17.50 | -- |
| -- | -- | Morphine Sulphate Injection 10 | Troikaa Pharmac | Morphitroy | Morphine Sulphate | Injection | 10x1ml | Injectio | 196.12 | 868000 | 44.72% | 19.61 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
-- |
-- | 1941134 | 100.00% | 18.56 | 21.52 | ||||||||
|
-- |
-- | Maximum | 19.61 | Minimum | 17.50 | ||||||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
19.41 | (Rs. In Lakhs) | -- | -- | -- | ||||||
|
-- |
Sum of PTR per unit considered for price calculation | -- | -- | -- | -- | 37.11 | -- | -- | -- | -- | |||
|
-- |
Number of Packs considered | -- | -- | -- | -- | -- | 2 | -- | -- | -- | -- | ||
|
-- |
Ceiling Price | -- | -- | -- | -- | -- | -- | 18.56 | -- | -- | -- | -- | |
|
-- |
Add : 16% Retailer Margin | -- | -- | -- | -- | -- | -- | 2.97 | -- | -- | -- | -- | |
|
-- |
MRP (without local taxes) | -- | -- | -- | -- | -- | -- | 21.52 | -- | -- | -- | -- | |
|
-- |
% Reduction with compared to Highest Price | -- | -- | -- | -- | -- | 5.38% | -- | -- | -- | -- | ||
|
-- |
-- |
-- | -- | -- | -- | -- | S.O. 2856(E) dated 20.09.13 | -- | -- | -- | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8 | 2.3.1.1 | Allopurinol Tablets 100 | GLAXOSMITH | ZYLORIC | ZYLORIC TAB | Tablets | 10 | Per T | 26.10 | 329000000 | 97.22% | 2.61 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | CIPLA | CIPLORIC | CIPLORIC TAB U | Tablets | 10 | Per Ta | 21.85 | 2761802 | 0.82% | 2.19 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | MANKIND | GUDLORIC | GUDLORIC TAB | Tablets | 10 | Per Ta | 15.24 | 1425736 | 0.42% | 1.52 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | INTAS PHARM | URITAS | URITAS TAB UN | Tablets | 10 | Per Ta | 12.80 | 830000 | 0.25% | 1.28 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | CIPLA | ZYRIK | ZYRIK TAB UNC | Tablets | 10 | Per Ta | 5.96 | 923900 | 0.27% | 0.60 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | SATVEN&MER | ALOPUR | ALOPUR TABS 1 | Tablets | 10 | Per Ta | 16.93 | 853159 | 0.25% | 1.69 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | NOVARTIS INT | LODIRIC | LODIRIC TAB U | Tablets | 10 | Per Ta | 19.05 | 657634 | 0.19% | 1.90 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | PSYCHOTROPI | PILORIC | PILORIC TABS 1 | Tablets | 10 | Per Ta | 22.89 | 381391 | 0.11% | 2.29 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | INGA | LOGOUT | LOGOUT TAB U | Tablets | 10 | Per Ta | 15.40 | 507272 | 0.15% | 1.54 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | RANBAXY* | RYLORIC | RYLORIC TABS | Tablets | 10 | Per Ta | 22.31 | 155255 | 0.05% | 2.23 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | ZYDUS CADIL | ZYPRINOL | ZYPRINOL TAB | Tablets | 10 | Per Ta | 27.25 | 65455 | 0.02% | 2.72 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | KAMRON | ALLGORIC | ALLGORIC TABS | Tablets | 10 | Per Ta | 17.33 | 29133 | 0.01% | 1.73 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | Esteem Pharm | Estinol | ESTINOL TABS | Tablets | 10×10 | Per Ta | 32.00 | 9344 | 0.00% | 0.32 | -- |
| -- | 2.3.1.1 | Allopurinol Tablets 100mg | Marsha Pharma | Puril | PURIL TABS 100 | Tablets | 10 | Per Ta | 16.65 | 804380 | 0.24% | 1.67 | -- |
| -- | -- |
-- |
-- | 338404461 | 100.00% | 1.80 | 2.08 | ||||||
| -- | -- |
-- |
-- | Maximum | 2.61 | Minimum | 0.60 | ||||||
| -- | -- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | |||
| -- | -- | Sum of MAT value considered for price calculation |
-- |
3326.86 | (Rs. In Lakhs) | -- | -- | -- | |||||
| -- | -- | Sum of PTR per unit considered for price calculation | -- | -- | -- | -- | 5.39 | -- | -- | -- | -- | ||
| -- | -- | Number of Packs considered | -- | -- | -- | -- | -- | 3 | -- | -- | -- | -- | |
| -- | -- | Ceiling Price | -- | -- | -- | -- | -- | -- | 1.80 | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | -- | -- | -- | -- | -- | -- | 0.29 | -- | -- | -- | -- |
| -- | -- | MRP (without local taxes) | -- | -- | -- | -- | -- | -- | 2.09 | -- | -- | -- | -- |
| -- | -- | % Reduction with compared to Highest Price | -- | -- | -- | -- | -- | 31.15% | -- | -- | -- | -- | |
| -- |
-- |
-- | -- | S.O. 2830(E) | -- | -- | -- | -- | |||||
PRICING OF NLEM DRUGS
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 3.03.1 | Dexchlorpheniramine Maleate Syrup 0.5mg/5ml | Fulford India | Polarmine Syrup Paed | ZYLORIC TAB | Syrup | 60 | ML | 27.72 | 8201534 | 100.00% | 0.46 | -- |
| -- |
-- |
-- | -- | -- | 8201534 | 100.00% | -- | -- | |||||
| -- | -- | Monopoly situation as M/s. Fulford is the only company having 100% market share | -- | -- | -- | -- | -- | -- | |||||
| -- | -- | PTR per unit | -- | 0.46 |
-- |
-- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Price fixed in the relevant sub-section for other drugs is as follows: | -- | -- | -- | -- | -- | -- | -- | ||||
| -- | -- | Medicines | Category | Route of Administration | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O. No. | Date | -- | % Reduction w.r.t. Highest Price | -- | -- |
| -- | Section: 3 – Antiallergics and Medicines used in Anaphylaxis |
-- |
-- |
-- |
-- |
||||||||
| -- | -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
-- |
-- |
||||
| -- | 1 | Adrenaline Bitartrate | P, S, T | Injection | 1 mg / ml | 37.24 | 1st meeting | 1565 | 14.6.2013 | -- | 48.32% |
-- |
|
| -- | 2 | Chlorpheniramine Maleate | P, S, T | Tablets | 4 mg | 0.10 | 5th meeting | 2232 | 22.07.2013 | -- | 76.21% |
-- |
|
| -- | 3 | Dexchlorpheniramine Maleate | P, S, T | Syrup | 0.5 mg / 5 ml | -- | -- |
-- |
-- |
-- |
|||
| -- | 4 | Dexamethasone | P, S, T | Tablets | 0.5 mg | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
||||
| -- | 5 | Dexamethasone | P, S, T | Injection | 4 mg / ml | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
||||
| -- | 6 | Hydrocortisone Sodium Succinate | P, S, T | Injection | 100 mg | 37.13 | 5th meeting | 2233 | 22.07.2013 | -- | 44.72% |
-- |
|
| -- | 7 | Pheniramine Maleate | P, S, T | Injection | 22.75 mg / ml | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
||||
| -- | 8 | Prednisolone | P, S, T | Tablets | 5 mg | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
||||
| -- | 9 | Prednisolone | Tablets | 10 mg | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
|||||
| -- | 10 | Prednisolone | Tablets | 20 mg | DPCO’ 19 |
-- |
DPCO’ 1995 |
-- |
|||||
| -- | 11 | Promethazine | P, S, T | Tablets | 10 mg | 7.99 | Proposed |
-- |
28.00% |
-- |
|||
| -- | 12 | Promethazine | Tablets | 25 mg | 2.49 | 1st meeting | 1566 | 14.6.2013 | -- | 12.70% |
-- |
||
| -- | 13 | Promethazine | Syrup | 5 mg / 5 ml | 0.21 | 1st meeting | 1552 | 14.6.2013 | -- | 43.30% | 28.00% | -- | |
| -- | Added Medicines |
-- |
-- |
-- |
|||||||||
| -- | 14 | Cetrizine | P,S,T | Tablets | 10mg | 1.81 | 3rd Meeting | 1875 | 28.06.2013 | -- | 49.14% |
-- |
|
| -- | 15 | Cetrizine | Syrup | 5 mg/ml | 0.54 | 3rd Meeting | 1876 | 28.06.2013 | -- | 56.48% |
-- |
||
| -- | -- | -- | -- | -- | -- | -- | Average Reduction |
-- |
44.86% | 27.72 | 15.285155 | ||
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | -- | Therefore, PTR per unit | 0.46 X (1-44. | 0.25 |
-- |
-- | -- | -- | -- | -- | -- | -- | |
|
-- |
Add: 16% Retailer Margin | -- | 0.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Ceiling Price per unit | -- | 0.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
S.O. 2831(E) dated 20.09.13 |
-- |
|||||||||||
PRICING OF NLEM DRUGS
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 3.0.8.1 | Promethazine Tablets 10mg | Abbott | Pherergan | ZYLORIC TAB | Tablet | 10 | mg | 11.10 | 26600000 | 100.00% | 1.11 | -- |
| -- |
-- |
-- | -- | -- | 26600000 | 100.00% | -- | -- | |||||
| -- | -- | Monopoly situation as M/s. Abbott is the only company as per available information | -- | -- | -- | -- | -- | -- | |||||
| -- | -- | PTR per unit | -- | 1.11 |
-- |
-- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Price fixed in the relevant sub-section for other drugs is as follows: | -- | -- | -- | -- | -- | -- | -- | ||||
| -- | -- | Medicines | Category | Route of Administration | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O. No. | Date | -- | % Reduction w.r.t. Highest Price | -- | -- |
| -- | Section: 3 – Antiallergics and Medicines used in Anaphylaxis |
-- |
-- |
-- |
-- |
||||||||
| -- | -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
-- |
-- |
||||
| -- | 1 | Promethazine | P,S,T | Tablets | 25 mg | 2.49 | 1st meeting | 1566 | 14.6.2013 | -- | 12.70% |
-- |
|
| -- | 2 | Promethazine | Syrup | 5 mg / 5 ml | 0.21 | 1st meeting | 1552 | 14.6.2013 | -- | 43.30% | -- | -- | |
| -- | -- | -- | -- | -- | -- | -- | Average Reduction |
-- |
28.00% |
-- |
|||
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | -- | Therefore, PTR per unit | 1.11 X (1-28 | 0.80 |
-- |
-- | -- | -- | -- | -- | -- | -- | |
|
-- |
Add: 16% Retailer Margin | -- | 0.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Ceiling Price per unit | -- | 0.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
S.O. 2832(E) dated 20.09.13 |
-- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | Price per Unit | – | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | 5.0.4.4 | Phenobarbiton Syrup 20 mg/5m | Abbott | Gardenal | Piperazine Solutio | Syrup | 60 | ml | 29.12 | 0.49 | -- |
|
-- |
Monopoly situation as o |
-- |
-- | -- | -- | ||||||
|
-- |
PTR per unit | -- | 0.49 |
-- |
-- | -- | -- | ||||
|
-- |
Price fixed in the releva |
-- |
-- | -- | -- | ||||||
|
-- |
-- | -- | -- | ||||||||
| -- | Section: 5 – Anticonvulsants/ Antiepileptics |
-- |
-- | ||||||||
| -- | -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O. No. | Date | -- | % Reduction w.r.t. Highest Price |
| -- | 1 | Phenobarbitone | P,S,T | Tablets | 30 mg | 0.93 | 3rd Meeting | 1877 | 28.06.2013 | -- | 43.59% |
| -- | 2 | Phenobarbitone | Tablets | 60 mg | 1.69 | 1st meeting | 1569 | 14.6.2013 | -- | 25.05% | |
| -- | 3 | Phenobarbitone | ST | Injection | 200 mg/ml | 18.75 | 6th meeting | 2526 | 21.8.2013 | -- | 14.88% |
| -- | Average Reduction |
-- |
27.84% | ||||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | ||
|
-- |
Therefore, PTR per unit | 0.49 X (1-27. | 0.35 | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Add: 16% Retailer Margin | -- | 0.06 | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Ceiling Price per unit | -- | 0.41 | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
S.O. 2833(E) dated 20.09.13 |
-- |
|||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 6.1.1.2 | Piperazine Solution 750 mg/5ml | Garima Healthcar | -- | Piperazine Solutio | Syrup | 30 | ml bottl | 6.55 | 169926.66 | #DIV/0! | 0.22 |
| -- | 6.1.1.2 | Piperazine Solution 750 mg/5ml | GSK | Antepar | Piperazine Solutio | Syrup | 30 | ml bottl | 12.24 | 43800000.00 | #DIV/0! | 0.41 |
|
-- |
Monopoly situation as o |
-- |
-- | 43969926.66 | #DIV/0! | -- | ||||||
|
-- |
PTR per unit |
-- |
-- | -- | -- | -- | ||||||
|
-- |
Price fixed in the releva |
-- |
-- | -- | -- | -- | ||||||
|
-- |
-- | -- | -- | -- | ||||||||
| -- | Section: 6 – Anti-infective Medicines |
-- |
-- | -- | ||||||||
| -- | 6.1 Anthelminthics |
-- |
-- | -- | ||||||||
| -- | 6.1.1 Intestinal Anthelminthics |
-- |
-- | -- | ||||||||
| -- | -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
-- | -- | |||
| -- | 1 | Albendazole | P,S,T | Tablets | 400 mg | 9.12 | 2nd Meeting | 1793 | 21.6.2013 | -- | 43.95% | -- |
| -- | 2 | Albendazole | Suspension | 200 mg/ 5 ml | 1.48 | 2nd Meeting | 1794 | 21.6.2013 | -- | 36.93% | -- | |
| -- | Added Medicines |
-- |
-- | -- | ||||||||
| -- | 3 | Piperazine | P,S,T | Tablets | 4.5 gm | Data NA |
-- |
-- | -- | |||
| -- | 4 | Solution | 750mg/5ml | -- |
-- |
-- | -- | |||||
| -- | Average Reduction |
-- |
40.44% | -- | ||||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | -- | ||
|
-- |
Therefore, PTR per unit | 0.41 X (1-40. | 0.24 | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Add: 16% Retailer Margin | -- | 0.04 | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Ceiling Price per unit | -- | 0.28 | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
-- |
S.O. 2834(E) dated 20.09.13 | -- | -- | -- | -- | -- | -- | -- | |||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.2.23.1 | Dapsone Tablets 50 mg | GLAXOSMITHKLINE* | DAPSONE | DAPSONE TABS PL.PINK 50 MG x 1000 | Tablets | 1000 | Per Tabs/caps | 216.28 | 60991 | 100.00 | 0.22 | 0.20 |
| -- | Monopoly c | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per unit as per IMS data | Re. 0.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Prices fixed in the relevant sub -section is as follows: | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| 6.2.3 Antileprosy medicines | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting N | S.o. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- |
| 1 | Clofazimine | P,S, T | Capsules | 50 mg | 1.28 | 1st meeti | 1581 (E) dt. 14.6.1 | 15.00 | -- | -- | -- | -- | -- |
| 2 | Clofazimine | -- | Capsules | 100 mg | 2.22 | 1st meeti | 1582 (E) dt. 14.6.1 | 22.19 | -- | -- | -- | -- | -- |
| 3 | Dapsone | P,S, T | Tablets | 50 mg | Not Fixed | -- | -- | -- | -- | -- | -- | -- | -- |
| 4 | Dapsone | P,S, T | Tablets | 100 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5 | Rifampicin | P,S, T | Tablets | 150 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 6 | Rifampicin | P,S, T | Tablets | 300 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 7 | Rifampicin | P,S, T | Capsules | 150 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 8 | Rifampicin | P,S, T | Capsules | 300 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Average R |
-- |
-- | -- | -- | 18.60 | -- | -- | -- | -- | -- | ||
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price of Dapson 50 mg as per Para 6(ii) of DPCO,2013 | 0.22*(1-18.6%) | 0.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Add margin 16% | -- | 0.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price | -- | 0.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
-- |
-- | S.O. 2835(E) dat | -- | -- | -- | -- | -- | -- | -- | -- |
-- |
||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- |
-- |
-- | |||||||||||
| 1 | 6.2.23.2 | Dapsone Tablets 100mg | GLAXOSMITHKLINE* | DAPSONE | DAPSONE TABS PL.WHIT 100 MG x 1000 | Tablets | 1000 | Per Tabs/caps | 238.24 | 124000 | 100 | 0.24 | 0.22 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Monopoly c | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per unit as per IMS/Co. data | Re. 0.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Prices fixed in the relevant sub -section is as follows: | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| 6.2.3 Antileprosy medicines | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting N | S.o. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- |
| 1 | Clofazimine | P,S, T | Capsules | 50 mg | 1.28 | 1st meeti | 1581 (E) dt. 14.6.1 | 15.00 | -- | -- | -- | -- | -- |
| 2 | Clofazimine | -- | Capsules | 100 mg | 2.22 | 1st meeti | 1582 (E) dt. 14.6.1 | 22.19 | -- | -- | -- | -- | -- |
| 3 | Dapsone | P,S, T | Tablets | 50 mg | Not Fixed | -- | -- | -- | -- | -- | -- | -- | -- |
| 4 | Dapsone | P,S, T | Tablets | 100 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5 | Rifampicin | P,S, T | Tablets | 150 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 6 | Rifampicin | P,S, T | Tablets | 300 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 7 | Rifampicin | P,S, T | Capsules | 150 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| 8 | Rifampicin | P,S, T | Capsules | 300 mg | DPCO, 95 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- |
-- |
-- | -- | Average Reducti | 18.60 | -- | -- | -- | -- | -- | ||
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price of Dapson 100 mg as per Para 6(ii) of DPCO,2013 | 0.24*(1-18.6%) | 0.19 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Add margin 16% | -- | 0.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price | -- | 0.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | S.O. 2836(E) dat |
-- |
-- |
-- |
-- | -- | |||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.2.4.1.1 | Ethambutol Tablets 200 mg | LUPIN LIMITED | COMBUTOL | COMBUTOL TAB | Tablets | 10 | Per Ta | 9.75 | 6264699 | #DIV/0! | 0.97 | -- |
| -- | 6.2.4.1.1 | Ethambutol Tablets 200 mg | THEMIS MEDIC | THEMIBUTOL | THEMIBUTOL TA | Tablets | 10 | Per Ta | 9.60 | 910074 | #DIV/0! | 0.96 | -- |
| -- |
-- |
Total | -- | 7174773 | #DIV/0! | 1.94 | 0.97 | ||||||
| 6.2.4 Antituberculosis medicines |
-- |
average price per unit | 0.97 | -- | |||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack |
-- |
-- | |||
| 1 | Ethambutol | P,S,T | Tablets | 200 mg | -- |
-- |
-- |
-- |
-- | ||||
| 2 | Ethambutol | P,S,T | Tablets | 400 mg | 2.17 | 1st meeti | 1583 (E) dt. 14.6.1 | 10.07 |
-- |
-- | |||
| 3 | Ethambutol | P,S,T | Tablets | 600 mg | 3.15 | 1st meeti | 1584 (E) dt. 14.6.1 | 10.39 |
-- |
-- | |||
| 4 | Ethambutol | P,S,T | Tablets | 800 mg | 3.74 | 1st meeti | 1585 (E) dt. 14.6.1 | 20.15 |
-- |
-- | |||
| -- | Average R |
-- |
-- | -- | -- | 13.54 |
-- |
-- | |||||
| -- |
-- |
-- | -- |
-- |
-- | ||||||||
| -- | Therfore,per unit price as per Para 6(i) of DPCO,2013 | 0.97*(1-13.54%) | 0.84 | -- | -- | -- | -- |
-- |
-- | ||||
| -- | Add margin 16% | 0.13 | -- | -- | -- | -- |
-- |
-- | |||||
| -- | Ceiling Price | 0.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
|
-- |
-- |
S.O. 2837(E) dated 20.09.13 | -- | -- | -- | -- | -- | -- |
-- |
||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.2.26.2 | Isoniazid Tablets 100 mg | MACLEODS PHARMA | SOLONEX | SOLONEX TABS DISPERS 100 MG x 10 | Tablets | 10 | Per Tabs/caps | 6.92 | 3618000 | #DIV/0! | 0.69 | -- |
| 2 | 6.2.26.2 | Isoniazid Tablets 100 mg | Low Cost Standard Therapeutics | N.A. | N.A. | Tablets | 25 x 10 | Per Tabs/caps | 2.25 | 22455 | #DIV/0! | 0.23 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3640455 | #DIV/0! | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.72 |
| Mo | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| PTR | -- | -- | Rs. 0.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Pric | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 6.2.4 Antituberculosis medicines | -- | -- | -- | -- | -- | -- | -- | -- | |||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- |
| 1 | Isoniazid | P,S,T | Tablets | 50 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 2 | Isoniazid | P,S,T | Tablets | 100 mg | nil | -- | -- | -- | -- | -- | -- | -- | -- |
| 3 | Isoniazid | P,S,T | Tablets | 300 mg | 1.27 | 5th Meeti | 2238 (E) dt.22.7.13 | 9.70 | -- | -- | -- | -- | -- |
| 4 | Isoniazid | P,S,T | Syrup | 100 mg/5ml | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Average R | -- | -- | -- | -- | -- | -- | 9.70 | -- | -- | -- | -- | -- |
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price as per Para 6(i) of DPCO,2013 | 0.69*(1-9.7%) | -- | 0.62 | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Add margin 16% | -- | 0.10 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Ceiling Price | -- | 0.72 | -- | -- | -- | -- | -- | -- | -- | -- | ||
|
-- |
-- |
-- | S.O. 2838(E) date | -- | -- | -- | -- | -- | -- |
-- |
|||
| Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.3.3.2 | Fluconazole Capsules 100 mg | TORRENT PHA | SYSCAN | SYSCAN CAPS 1 | Capsules | 4 | Per Ta | 82.30 | 2377943 | 87.21% | 20.57 | -- |
| 6.3.3.2 | Fluconazole Capsules 100 mg | BOMBAY TABL | FLUCAN | FLUCAN CAPS 1 | Capsules | 4 | Per Ta | 81.91 | 348609 | 12.79% | 20.48 | -- |
|
-- |
-- | 2726552 | 100.00% | 20.53 | -- | |||||||
|
-- |
-- | -- | -- | -- | -- | |||||||
| -- |
-- |
-- | -- | Maximum | 20.57 | minimum | 20.48 | |||||
| -- | Sum of MAT Value considered for price calculation | 27.27 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Number of Packs considered | -- | 2 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of PTR per unit considered for price calculation | 41.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Average PTR | -- | 20.53 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Add : 16% Retailer Margin | -- | 3.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price (without local ta | -- | 23.81 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | % Reduction as compared to highest price | 0.21% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- |
-- |
S.O. 2849(E) dated 20.09.13 | -- | -- | -- | -- | -- | -- |
-- |
|||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.4.1.1.3.1 | Acyclovir Suspension 400 mg / 5 ml | GLAXOSMITHKLINE* | ZOVIRAX | ZOVIRAX SUSP 400 MG 100 ML x 1 (/5ML) | Liquid | 100 | ML | 183.82 | 128000 | -- | 1.84 | 1.32 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Monopoly c | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per unit as per company data | -- | Re. 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Prices fixed in the relevant sub -section is as follows: | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| 6.4 Antiviral medicines | -- | -- | -- | -- | -- | -- | -- | -- | |||||
| 6.4.1 Antiherpes medicines |
-- |
-- | -- | -- | -- | ||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- |
| 1 | Acyclovir | S, T | Tablets | 200 mg | 7.30 | 1st meeting | 1590 (E) dt. 14.6.13 | 57.52 | -- | -- | -- | -- | -- |
| 2 | Acyclovir | S, T | Tablets | 400 mg | 11.64 | 3rd Meeting | 1887 (E) dt. 28.6.13 | 15.89 | -- | -- | -- | -- | -- |
| 3 | Acyclovir | S, T | Injection | 250 mg | 460.05 | 4th Meeting | 2056(E) dt. 05.07.13 | 40.98 | -- | -- | -- | -- | -- |
| 4 | Acyclovir | S, T | Injection | 500 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5 | Acyclovir | S, T | Suspension | 400 mg / 5 ml | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Average R |
-- |
-- | -- | -- | 38.13 | -- | -- | -- | -- | -- | ||
| -- | Therfore,per unit price as per Para 6(i) of DPCO,2013 | 1.84*(1-38.13%) | 1.14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Add margin 16% | -- | -- | 0.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price | -- | -- | 1.32 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | S.O. 2839(E) d | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.4.2.1.1.1 | Didanosine Tablets 250 mg | ALKEM* | DDRETRO | DDRETRO ENTER C.TABS 250 MG x 30 | Tablets | 30 | Per Tabs/caps | 701.00 | 701 | -- | 23.37 | 23.93 |
| 2 | 6.4.2.1.1.1 | Didanosine Tablets 250 mg | CIPLA | DINEX | DINEX CAPS ER 250 MG x 30 | Capsules | 30 | Per Tabs/caps | 727.02 | 1527469 | -- | 24.23 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | Price to Retail | -- | -- | 23.37 | -- |
| -- | Monopoly | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per un | -- | -- | Rs. 23.37/tab | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Prices fixe | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 6.4.2.1 Nucleoside reverse transcriptase inhibitors | -- | -- | -- | -- | -- | -- | -- | -- | |||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- |
| 1 | Didanosine | S, T | Tablets | 250 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 2 | Didanosine | S, T | Tablets | 400 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 3 | Lamivudine | S, T | Tablets | 150 mg | 9.40 | 3rd Meeting | 1888 (E) dt. 28.6.13 | 15.57 | -- | -- | -- | -- | -- |
| 4 | Lamivudine + Nevirapine + Stavudine | S, T | Tablets | 150 mg + 200 mg+ 30 mg | 17.29 | 1st meeting | 1591 (E) dt. 14.6.13 | 16.02 | -- | -- | -- | -- | -- |
| 5 | Lamivudine + Zidovudine | S, T | Tablets | 150 mg + 300 mg | 19.63 | 1st meeting | 1592 (E) dt. 14.6.13 | 13.31 | -- | -- | -- | -- | -- |
| 6 | Stavudine | S, T | Capsules | 15 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 7 | Stavudine | S, T | Capsules | 30 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 8 | Stavudine | S, T | Capsules | 40 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 9 | Zidovudine | S, T | Tablets | 100 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 10 | Zidovudine | S, T | Tablets | 300 mg | 14.97 | 3rd Meeting | 1913 (E) dt.28.06.13 | 2.00 | -- | -- | -- | -- | -- |
| -- | Average R | -- | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- | -- |
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price as per Para 6(ii) of DPCO,2013 | 23.37*(1-11.73% | 20.63 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Add margin 16% | 3.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Ceiling Price | 23.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- |
-- |
-- | S.O. 2840(E) d |
-- |
-- |
-- |
-- | -- | |||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.4.6.2 | Stavudine Capsules 30 mg | CIPLA | STAVIR | STAVIR CAPS 30 | Capsules | 10 | Per Ta | 26.90 | 268353 | -- | 99.35% | 2.69 | 2.7545331 |
| 2 | 6.4.6.2 | Stavudine Capsules 30 mg | EMCURE* | STADINE | STADINE CAPS 3 | Capsules | 60 | Per Ta | 175.67 | 1757 | -- | 0.65% | 2.93 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 270110 | -- | 1.00 | -- | -- |
| -- | Monopoly | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per un | -- | -- | Rs. 2.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Prices fixe | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 6.4.2.1 Nucleoside reverse transcriptase inhibitors | -- | -- | -- | -- | -- | -- | -- | -- | -- | |||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | -- | -- | -- | -- | -- |
| 1 | Didanosine | S, T | Tablets | 250 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 2 | Didanosine | S, T | Tablets | 400 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 3 | Lamivudine | S, T | Tablets | 150 mg | 9.40 | 3rd Meeting | 1888 (E) dt. 28.6.13 | 15.57 | -- | -- | -- | -- | -- | -- |
| 4 | Lamivudine + Nevirapine + Stavudine | S, T | Tablets | 150 mg + 200 mg+ 30 mg | 17.29 | 1st meeting | 1591 (E) dt. 14.6.13 | 16.02 | -- | -- | -- | -- | -- | -- |
| 5 | Lamivudine + Zidovudine | S, T | Tablets | 150 mg + 300 mg | 19.63 | 1st meeting | 1592 (E) dt. 14.6.13 | 13.31 | -- | -- | -- | -- | -- | -- |
| 6 | Stavudine | S, T | Capsules | 15 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 7 | Stavudine | S, T | Capsules | 30 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 8 | Stavudine | S, T | Capsules | 40 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 9 | Zidovudine | S, T | Tablets | 100 mg | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 10 | Zidovudine | S, T | Tablets | 300 mg | 14.97 | 3rd Meeting | 1913 (E) dt.28.06.13 | 2.00 | -- | -- | -- | -- | -- | -- |
| -- | Average R | -- | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- | -- | -- |
| -- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price as per Para 6(ii) of DPCO,2013 | 2.69*(1-11.73%) | -- | 2.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | Add margin 16% | -- | 0.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Ceiling Price | -- | 2.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- |
-- |
-- |
S.O. 2841(E) date |
-- |
-- |
-- |
-- | -- | -- | |||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.4.2.1.5.3 | Stavudine Capsules 40 mg | CIPLA | STAVIR | STAVIR CAPS 40 MG x 10 | Capsules | 10 | Per Tabs/caps | 30.46 | 222083 | 3.05 | 3.12 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Monopoly | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | PTR per un | -- | -- | Rs. 3.05 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Prices fixe | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 6.4.2.1 Nucleoside reverse transcriptase inhibitors | -- | -- | -- | -- | -- | -- | -- | |||||
| 1 | Didanosine | S, T | Tablets | 250 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 2 | Didanosine | S, T | Tablets | 400 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 3 | Lamivudine | S, T | Tablets | 150 mg | 9.40 | 3rd Meeting | 1888 (E) dt. 28.6.13 | 15.57 | -- | -- | -- | -- |
| 4 | Lamivudine + Nevirapine + Stavudine | S, T | Tablets | 150 mg + 200 mg+ 30 mg | 17.29 | 1st meeting | 1591 (E) dt. 14.6.13 | 16.02 | -- | -- | -- | -- |
| 5 | Lamivudine + Zidovudine | S, T | Tablets | 150 mg + 300 mg | 19.63 | 1st meeting | 1592 (E) dt. 14.6.13 | 13.31 | -- | -- | -- | -- |
| 6 | Stavudine | S, T | Capsules | 15 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 7 | Stavudine | S, T | Capsules | 30 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 8 | Stavudine | S, T | Capsules | 40 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 9 | Zidovudine | S, T | Tablets | 100 mg | -- | -- | -- | -- | -- | -- | -- | -- |
| 10 | Zidovudine | S, T | Tablets | 300 mg | 14.97 | 3rd Meeting | 1913 (E) dt.28.06.13 | 2.00 | -- | -- | -- | -- |
| -- | Average R | -- | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- |
| -- |
-- |
-- | -- | -- | -- | -- | -- | |||||
| -- | Therfore,per unit price as per Para 6(ii) of DPCO,2013 | 3.05*(1-11.73%) | -- | 2.69 | -- | -- | -- | -- | -- | -- | -- | |
| -- | Add margin 16% | -- | 0.43 | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Ceiling Price | -- | 3.12 | -- | -- | -- | -- | -- | -- | -- | ||
| -- |
-- |
-- |
S.O. 2842(E) date |
-- |
-- |
-- |
-- | |||||
PRICING OF NLEM DRUGS
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | – | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.4.1 & 2.2. | Morphine Sulphate Tablets 10m | Verve Health Car | Vermor | Morphine Sulphate | Tablet | 10 | -- | 42.00 | 1966323 | 37.03% | 4.20 | -- |
| -- | 8.4.1 & 2.2. | Morphine Sulphate Tablets 10m | Verve Health Car | Vermor | Morphine Sulphate | Tablet | 10 | -- | 63.00 | 422856 | 7.96% | 6.30 | -- |
| -- | 8.4.1 & 2.2. | Morphine Sulphate Tablets 10m | Modi MundiPhar | MORCON | Morphine Sulphate | Tablet | 10X10 | -- | 296.97 | 837000 | 15.76% | 2.97 | -- |
| -- | 8.4.1 & 2.2. | Morphine Sulphate Tablets 10m | Troikaa Pharmac | Morphitroy | Morphine Sulphate | Tablet | 10X10 | -- | 392.23 | 2084000 | 39.25% | 3.92 | -- |
|
-- |
-- | 5310179 | 100.00% | 4.35 | 5.04 | ||||||||
|
-- |
-- | Maximum | 6.30 | Minimum | 2.97 | ||||||||
|
-- |
-- | -- | -- | -- | -- | ||||||||
|
-- |
-- | -- | -- | -- | -- | ||||||||
|
-- |
-- |
-- | -- | -- | -- | -- | -- | -- | -- | ||||
|
-- |
Sum of MAT value considered for price calculation |
-- |
53.10 | (Rs. In Lakhs) | -- | -- | -- | ||||||
|
-- |
Sum of PTR per unit considered for price calculation | -- | -- | -- | -- | 17.39 | -- | -- | -- | -- | |||
|
-- |
Number of Packs considered | -- | -- | -- | -- | -- | 4 | -- | -- | -- | -- | ||
|
-- |
Ceiling Price | -- | -- | -- | -- | -- | -- | 4.35 | -- | -- | -- | -- | |
|
-- |
Add : 16% Retailer Margin | -- | -- | -- | -- | -- | -- | 0.70 | -- | -- | -- | -- | |
|
-- |
MRP (without local taxes) | -- | -- | -- | -- | -- | -- | 5.04 | -- | -- | -- | -- | |
|
-- |
% Reduction with compared to Highest Price | -- | -- | -- | -- | -- | 30.98% | -- | -- | -- | -- | ||
|
-- |
S.O. 2857(E) dated 20.09.13 |
-- |
|||||||||||
| Unique no. as per NLEM | Compositi | Company | Brand | Pack size (ml) | Price to Retailer | MAT Value | MAT % | Price per unit |
| 10.2 | Heparin So | GLAND PHARMA | HEP 5 INJ VIAL | 5 | 85.52 | 3238594 | 1.35% | 17.10 |
| -- | Heparin So | GLAND PHARMA | HEPARIN SODI | 5 | 53.33 | 1912968 | 0.80% | 10.67 |
| -- | Heparin So | BIOLOGICAL E | BEPARINE INJ | 5 | 194.67 | 97232377 | 40.52% | 38.93 |
| -- | Heparin So | SAMARTH PHARMA | CAPRIN INJ VIA | 5 | 160.00 | 9594883 | 4.00% | 32.00 |
| -- | Heparin So | TROIKAA PHARMA | NUPARIN INJ VI | 5 | 241.38 | 16716000 | 6.97% | 48.28 |
| -- | Heparin So | TROIKAA PHARMA | TROYHEPINJ VI | 5 | 241.38 | 35155000 | 14.65% | 48.28 |
| -- | Heparin So | VHB LIFESCIENCES | V-PARIN INJ VI | 5 | 35.50 | 1128829 | 0.47% | 7.10 |
| -- | Heparin So | M/s NIRMA | HEPARIN SODI | 5 | 187.80 | 63834697 | 26.60% | 37.56 |
| -- | Heparin So | M/s Arco Life Sciences | HEPARIN SODI | 5 | 120.20 | 75600 | 0.03% | 24.04 |
| -- | Heparin So | M/s Bharat Biotech | HEPASOL V | 5 | 194.25 | 3109807 | 1.30% | 38.85 |
| -- | Heparin So | M/s Claris Life Sciences | HEPARIN SODI | 5 | 217.37 | 7955742 | 3.32% | 43.47 |
|
-- |
-- | -- | -- | ######## | 100.00% | 35.02 | ||
| -- | -- | -- | -- | -- | Maximum | 48.28 | Minimum | 0.00 |
| -- | Sum of MA | -- | -- | 2387.50 | (Rs. in Lakhs) |
-- |
||
| -- | Sum of PT | -- | -- | 315.14 |
-- |
|||
| -- | Number of | -- | -- | 9 |
-- |
|||
| -- | Ceiling Pri | -- | -- | 35.02 |
-- |
|||
| -- | Add : 16% | -- | -- | 5.60 |
-- |
|||
| -- | MRP (with | -- | -- | 40.62 |
-- |
|||
| -- | % Reducti | -- | -- | 27.47% |
-- |
|||
|
-- |
S.O. 2858(E) dated 20.09.13 |
-- |
||||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 12.2.3.1 | Diltiazem Injection 5 mg/ ml | TORRENT PHARMA | DILZEM | DILZEM INJ VIAL 5 MG 5 ML x 1 (/1ML) | ML | 5 | ML | 21.54 | 4071735 | 4.31 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Monopoly situation as IMS Health has data is for one company i.e. M/s Torrent Pharma. | -- | -- | -- | -- | -- | -- | ||||
| -- | PTR per unit as per IMS Health data- 4.31 per ml | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Prices fixe | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 12.2- anti arrythmatic medicine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | S.O. No. & Date | -- | % reduction to Highest price pack | -- | -- | -- |
| 1 | Diltiazem Tablets | S, T | Tablets | 30 mg | 2.27 | 1622 (E) dated 14.06.2013 | -- | 33.04 | -- | -- | -- |
| 2 | Diltiazem Tablets | S, T | Tablets | 60 mg | 4.79 | 1899(E) dated 28.06.2013 | -- | 46.46 | -- | -- | -- |
| -- | Average Reduction | -- | -- | -- | -- | -- | -- | 39.75 | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Therfore,per unit price as per Para 6(i) of DPCO,2013 | -- | 4.31*(1-39.77%) | -- | 2.60 | -- | -- | -- | -- | -- | -- |
| -- | Add margin 16% | -- | -- | -- | 0.42 | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price | -- | -- | -- | 3.02 | -- | -- | -- | -- | -- | -- |
|
-- |
S.O. 2843(E) dated 20.09.13 |
-- |
|||||||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer (Rs.) | MAT Value as on 31st May 2012 (Rs.) | Price per Unit (Rs.) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 12.3.6.3 | Nifedipine sustained Release Capsule 10mg | Abbott Healthcare Pvt. Ltd | CARDULES RETARD | CARDULES CAPS RETARD 10 MG x 10 | Capsule | 10 | Per capsule | 17.03 | 2532355 | 1.70 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Monopoly situation as IMS Health has data is for one company i.e. M/s Abbott Healthcare Pvt. Ltd | -- | -- | -- | -- | -- | -- | |||||
| PTR per unit as per Company data is- Rs. 1.70 per capsule | -- | -- | |||||||||
| Prices fixed in the relevant sub -section for the schedule formulation is as follows: | -- | -- | -- | -- | -- | -- | -- | ||||
| 12.3- Antihypertensive medicine | -- | -- | -- | ||||||||
| S.No. | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | S.O. No. & Date | % reduction to Highest price pack |
|---|---|---|---|---|---|---|---|
| -- | -- | -- | -- | -- | -- | -- | -- |
| 1 | Nifedipine Tablets 10mg | S, T | Tablets | 10 mg | 1.13 | 1638(E) dated 14.06.2013 | 16.96 |
| 2 | Nifedipine Sustained release tablets 10mg | S, T | Tablets | 10 mg | 1.42 | 1901(E) dated 28.06.2013 | 16.79 |
| 3 | Nifedipine Sustained release tablets 20 mg | S, T | Tablets | 20mg | 1.90 | 2061(E) dated 05.07.2013 | 24.51 |
| 4 | Nifedipine Capsules 10 mg | S, T | Capsules | 10 mg | 1.18 | 1637(E) dated 14.06.2013 | 12.9 |
| 5 | Nifedipine Capsules 5 mg | S, T | Capsules | 5mg | 0.86 | 1900(E) dated 28.06.2013 | 6.44 |
| A | Average Reduction | -- | -- | -- | -- | -- | 15.52 |
| B | Therfore,per unit price for Nifedipine sustained release capsule of 10 mg as per Para 6(i) of DPCO,2013 | 1.70*(1-15.52%) | 1.44 | -- | -- | ||
| C | Add margin 16% | -- | -- | -- | 0.23 | -- | -- |
| D | Ceiling Price per capsule(Rs.) | -- | -- | -- | 1.67 | -- | -- |
|
-- |
S.O. 2844(E) dated 20.09.13 | -- | |||||
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer (Rs.) | MAT Value as on 31st May 2012 (Rs.) | Price per Unit (Rs.) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 12.3.6.3 | Nifedipine sustained Release Capsule 20mg | Abbott Healthcare Pvt. Ltd | CARDULES RETARD | CARDULES CAPS RETARD 20 MG x 10 | Capsule | 10 | Per capsule | 22.39 | 2498956 | 2.24 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Monopoly situation as IMS Health has data is for one company i.e. M/s Abbott Healthcare Pvt. Ltd | -- | -- | -- | -- | -- | -- | |||||
| PTR per unit as per Company data is- 2.24 per capsule | -- | -- | |||||||||
| Prices fixed in the relevant sub -section for the schedule formulation is as follows: | -- | -- | -- | -- | -- | -- | -- | ||||
| 12.3- Antihypertensive medicine | -- | -- | -- | ||||||||
| S.No. | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | S.O. No. & Date | % reduction to Highest price pack | |
|---|---|---|---|---|---|---|---|---|
| 1 | Nifedipine Tablets 10mg | S, T | Tablets | 10 mg | 1.13 | 1638(E) dated 14.06.2013 | 16.96 | |
| 2 | Nifedipine Sustained release tablets 10mg | S, T | Tablets | 10 mg | 1.42 | 1901(E) dated 28.06.2013 | 16.79 | |
| 3 | Nifedipine Sustained release tablets 20 mg | S, T | Tablets | 20mg | 1.90 | 2061(E) dated 05.07.2013 | 24.51 | |
| 4 | Nifedipine Capsules 10 mg | S, T | Capsules | 10 mg | 1.18 | 1637(E) dated 14.06.2013 | 12.9 | |
| 5 | Nifedipine Capsules 5 mg | S, T | Capsules | 5mg | 0.86 | 1900(E) dated 28.06.2013 | 6.44 | |
| A | Average Reduction | -- | -- | -- | -- |
-- |
15.52 | |
| B | Therfore,per unit price for Nifedipine sustained release capsule of 20 mg as per Para 6(i) of DPCO,2013 | 2.24*(1-15.52%) | 1.89 | -- | -- | -- | ||
| C | Add margin 16% | -- | -- | -- | 0.30 | -- | -- | -- |
| D | Ceiling Price per capsule (Rs.) | -- | -- | -- | 2.19 | -- | -- | -- |
|
-- |
S.O. 2845(E) dated 20.09.13 | -- | ||||||
| USN | NLEM Des | Molecule_Desc | COMPANY | BRANDS | Pack Description | Dosage | Pack size | ML | Price to Retailer (PR) | MAT Value as on 31.05.2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | ALKEM* | CALKEM | CALKEM LOTION | Lotion | 60 | ML | 48.0 | 11968658 | 2.66% | 0.80 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | ALKEM* | CALKEM | CALKEM LOTION | Lotion | 100 | ML | 75.6 | 736894 | 0.16% | 0.76 | -- |
| 13.3 | Calamine L | CALAMINE | CFL | EFATOP-C | EFATOP-C LOTI | Lotion | 75 | ML | 61.0 | 2815941 | 0.63% | 0.81 | -- |
| 13.3 | Calamine L | CALAMINE + ZINC OXIDE | DERMOCARE | CALDERM | CALDERM LOTIO | Lotion | 100 | ML | 57.9 | 1110227 | 0.25% | 0.58 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | DERMOCARE | VERACAL | VERACAL LOTIO | Lotion | 125 | ML | 60.5 | 1573067 | 0.35% | 0.48 | -- |
| 13.3 | Calamine L | CALAMINE + SIMETICONE + | DERMOCARE | CALDERM | CALDERM CREA | Cream | 20 | G | 29.0 | 298938 | 0.07% | 1.45 | -- |
| 13.3 | Calamine L | CALAMINE + SIMETICONE + | DERMOCARE | CALDERM | CALDERM CREA | Cream | 20 | G | 29.0 | 298938 | 0.07% | 1.45 | -- |
| 13.3 | Calamine L | CALAMINE + CINNAMOMUM | DR REDDYS LA | VENUSIA SOF | VENUSIA SOFT L | Lotion | 75 | ML | 149.2 | 7367010 | 1.64% | 1.99 | -- |
| 13.3 | Calamine L | CALAMINE + CETRIMIDE + DI | ELAN PHARMA | PROTECTOD | PROTECTODER | Oint | 10 | G | 25.4 | 1127576 | 0.25% | 2.54 | -- |
| 13.3 | Calamine L | CALAMINE + CETRIMIDE + DI | ELAN PHARMA | PROTECTOD | PROTECTODER | Oint | 25 | G | 39.2 | 1045252 | 0.23% | 1.57 | -- |
| 13.3 | Calamine L | CALAMINE + CETRIMIDE BR | ESKAG PHARM | SUFRATE-TO | SUFRATE-TOPIC | Cream | 25 | G | 30.2 | 295604 | 0.07% | 1.21 | -- |
| 13.3 | Calamine L | CALAMINE + PARAFFIN OIL | GLAXOSMITHK | DERMOCALM | DERMOCALM LO | Lotion | 100 | ML | 80.7 | 65189087 | 14.51% | 0.81 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | HEGDE & HEG | DERMADEW- | DERMADEW-CAL | Lotion | 100 | ML | 126.9 | 40170015 | 8.94% | 1.27 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | IND-SWIFT | CALSKIN | CALSKIN LOTIO | Lotion | 100 | ML | 14.3 | 25092 | 0.01% | 0.14 | -- |
| 13.3 | Calamine L | CALAMINE + PARAFFIN OIL | IND-SWIFT | CALEEZ | CALEEZ LOTION | Lotion | 60 | ML | 61.3 | 814689 | 0.18% | 1.02 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | INTAS PHARMA | CALACARE | CALACARE LOTI | Lotion | 100 | ML | 16.8 | 984955 | 0.22% | 0.17 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | INTAS PHARMA | CALACARE | CALACARE LOTI | Lotion | 50 | ML | 13.8 | 1027343 | 0.23% | 0.28 | -- |
| 13.3 | Calamine L | CALAMINE + GLYCEROL + ZI | INVIDA INDIA | CALAK | CALAK LOTION 5 | Lotion | 50 | ML | 21.1 | 8839532 | 1.97% | 0.42 | -- |
| 13.3 | Calamine L | CALAMINE + GLYCEROL + ZI | INVIDA INDIA | CALAK | CALAK LOTION 1 | Lotion | 100 | ML | 32.5 | 6960507 | 1.55% | 0.33 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | INVIDA INDIA | CALAK-A | CALAK-A LOTIO | Lotion | 100 | ML | 64.0 | 1156451 | 0.26% | 0.64 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | INVIDA INDIA | CALAK-A | CALAK-A LOTIO | Lotion | 50 | ML | 36.8 | 1049949 | 0.23% | 0.74 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS EXTRA | IPCA LABS | ALLSUTH | ALLSUTH LOTIO | Lotion | 100 | ML | 89.1 | 9400788 | 2.09% | 0.89 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | JOHNSON & JO | CALADRYL | CALADRYL LOTI | Lotion | 50 | ML | 30.3 | 18435445 | 4.10% | 0.61 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | JOHNSON & JO | CALADRYL | CALADRYL LOTI | Lotion | 100 | ML | 44.0 | 14725544 | 3.28% | 0.44 | -- |
| 13.3 | Calamine L | CALAMINE + PARAFFIN OIL | MANKIND | CALAPURE | CALAPURE LOTI | Lotion | 100 | ML | 76.2 | 15898089 | 3.54% | 0.76 | -- |
| 13.3 | Calamine L | CALAMINE + PARAFFIN OIL | MANKIND | CALAPURE | CALAPURE LOTI | Lotion | 50 | ML | 43.1 | 38809221 | 8.64% | 0.86 | -- |
| 13.3 | Calamine L | AVOBENZONE + BENZOPHE | MARC LABORA | MELASCREE | MELASCREEN C | Cream | 70 | G | 57.3 | 603843 | 0.13% | 0.82 | -- |
| 13.3 | Calamine L | ALLANTOIN + ALOE BARBAD | MED MANOR O | CALORA | CALORA LOTION | Lotion | 100 | ML | 71.6 | 1513258 | 0.34% | 0.72 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | MERIDIAN LAB | MELADRYL | MELADRYL LOTI | Lotion | 50 | ML | 27.3 | 1002236 | 0.22% | 0.55 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | MICRO LABS* | CALOSOFT | CALOSOFT LOTI | Lotion | 100 | ML | 93.8 | 40114773 | 8.93% | 0.94 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | MICRO LABS* | CALOSOFT | CALOSOFT LOTI | Lotion | 50 | ML | 53.8 | 19676576 | 4.38% | 1.08 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | NOVARTIS INTL | VEROKA | VEROKA LOTION | Lotion | 100 | ML | 76.0 | 4851252 | 1.08% | 0.76 | -- |
| 13.3 | Calamine L | CALAMINE | PALSON DRUG | LINICAL | LINICAL LOTION | Lotion | 100 | ML | 53.8 | 25740351 | 5.73% | 0.54 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + CALA | PALSON DRUG | LINIMOIST | LINIMOIST LOTI | Lotion | 100 | ML | 84.5 | 6239057 | 1.39% | 0.85 | -- |
| 13.3 | Calamine L | CALAMINE + ZINC OXIDE | PARKER ROBIN | PEERLIN | PEERLIN LOTIO | Lotion | 50 | ML | 37.3 | 1976215 | 0.44% | 0.75 | -- |
| 13.3 | Calamine L | CALAMINE + HAMAMELIS VI | PIRAMALHEAL | LACTO-CALA | LACTO-CALAMIN | Lotion | 10 | ML | 7.9 | 649552 | 0.14% | 0.79 | -- |
| 13.3 | Calamine L | CALAMINE + HAMAMELIS VI | PIRAMALHEAL | LACTO-CALA | LACTO-CALAMIN | Lotion | 30 | ML | 26.0 | 13335817 | 2.97% | 0.87 | -- |
| 13.3 | Calamine L | CALAMINE + HAMAMELIS VI | PIRAMALHEAL | LACTO-CALA | LACTO-CALAMIN | Lotion | 60 | ML | 55.4 | 19827251 | 4.41% | 0.92 | -- |
| 13.3 | Calamine L | CALAMINE + HAMAMELIS VI | PIRAMALHEAL | LACTO-CALA | LACTO-CALAMIN | Lotion | 120 | ML | 82.6 | 15750704 | 3.51% | 0.69 | -- |
| 13.3 | Calamine L | ALOE BARBADENSIS + BENT | PSYCHOTROPI | CALADIL | CALADIL LOTION | Lotion | 60 | ML | 50.1 | 915956 | 0.20% | 0.84 | -- |
| 13.3 | Calamine L | CALAMINE + PARAFFIN OIL | RANBAXY* | CIALO | CIALO LOTION 1 | Lotion | 100 | ML | 85.2 | 5716963 | 1.27% | 0.85 | -- |
| 13.3 | Calamine L | CALAMINE + CAMPHOR + DI | SOMATICO | HISTO-CALA | HISTO-CALAMIN | Lotion | 60 | ML | 33.0 | 9209760 | 2.05% | 0.55 | -- |
| 13.3 | Calamine L | CALAMINE + CETRIMIDE BR | U S V | SILODERM | SILODERM CRE | Cream | 20 | G | 33.4 | 29788116 | 6.63% | 1.67 | -- |
| 13.3 | Calamine L | CALAMINE + DIPHENHYDRA | WOCKHARDT L | DERMIDRYL | DERMIDRYL LOT | Lotion | 100 | ML | 18.5 | 218578 | 0.05% | 0.19 | -- |
|
-- |
-- |
-- |
-- | -- | 449255070 | 100.00% | 0.84 | -- | |||||
|
-- |
-- |
-- |
-- | -- | Maximum | 1.99 | Minimum | 0.33 | |||||
| -- | -- | -- | -- | -- | -- | -- |
-- |
-- | -- | -- | % | -- | |
| -- | Sum of MA | -- | -- | -- |
-- |
-- |
-- | -- | -- | 4316.07 | (Rs. In Lakh | ||
| -- | Sum of PT | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.80 | -- |
| -- | Number of | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 26 | -- |
| -- | Ceiling Pri | -- | -- | -- | -- | -- |
-- |
-- | -- | -- | 0.84 | -- | |
| -- | Add : 16% | -- | -- | -- | -- | -- |
-- |
-- | -- | -- | 0.13 | -- | |
| -- | MRP (with | -- | -- | -- | -- | -- |
-- |
-- | -- | -- | 0.97 | -- | |
| -- | % Reducti | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.84% | -- |
|
-- |
S.O. 2859(E) dated 20.09.13 | ||||||||||||
| Unique no. as per NLEM | Compositi | Company | Brand | Pack size (ml) | Price to Retailer | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|
| 15.2 | Glutaraldeh | M/s PSK Pharma Pvt. Ltd. | GLUTISHIELD | 1000 | 116.51 | 26301 | 7.84% | 0.12 |
| -- | Glutaraldeh | M/s PSK Pharma Pvt. Ltd. | GLUTISHIELD | 5000 | 214.45 | 60462 | 18.01% | 0.04 |
| -- | Glutaraldeh | M/s PSK Pharma Pvt. Ltd. | STERIDEX | 5000 | 232.84 | 35000 | 10.43% | 0.05 |
| -- | Glutaraldeh | M/s PSK Pharma Pvt. Ltd. | NUHOSPISOL | 1000 | 94.00 | 10788 | 3.21% | 0.09 |
| -- | Glutaraldeh | M/s PSK Pharma Pvt. Ltd. | NUHOSPISOL | 5000 | 235.00 | 183461 | 54.66% | 0.05 |
| -- | Glutaraldeh | Swastik Pharmaceticals | GLUTIAL | 5000 | 340.93 | 19613 | 5.84% | 0.07 |
| -- | -- |
-- |
-- | -- | 335625 | 100.00% | 0.07 | |
| -- | -- | -- | -- | -- | Maximum | 0.12 | Minimum | 0.04 |
| -- | Sum of MA | -- | -- | 3.36 | (Rs. in Lakhs) |
-- |
||
| -- | Sum of PT | -- | -- | 0.42 |
-- |
|||
| -- | Number of | -- | -- | 6 |
-- |
|||
| -- | Ceiling Pri | -- | -- | 0.07 |
-- |
|||
| -- | Add : 16% | -- | -- | 0.01 |
-- |
|||
| -- | MRP (with | -- | -- | 0.08 |
-- |
|||
| -- | % Reducti | -- | -- | 40.61% |
-- |
|||
|
-- |
S.O. 2860(E) dated 20.09.13 |
-- |
||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.1.6.1 | Sulphacetamide Sodium Dro | ALLERGAN | ALBUCID | ALBUCID EYE D | Opthal Li | 10 | ML | 18.06 | 2,420,525 | 23.70% | 1.81 | -- |
| -- | 21.1.6.1 | Sulphacetamide Sodium Drops | East India | Locula | LOCULA EYE DR | Opthal Li | 10 | ML | 31.00 | 7,793,937 | 76.30% | 3.10 | -- |
| -- | 21.1.6.1 | Sulphacetamide Sodium Drops | INDOCO* | TOPCULA | TOPCULA EYE D | Opthal Liq | 10 | ML | 9.53 | 343.00 | 0.00% | 0.95 | -- |
| -- | -- |
-- |
-- | -- | -- | -- | 10,214,805 | 100.00% | 2.45 | 2.85 | |||
| -- | -- |
-- |
-- | -- | -- | -- | maximum | 3.10 | minimum | 1.81 | |||
| -- | -- |
-- |
-- | -- | -- | -- | -- | -- |
-- |
||||
| -- | -- | Sum of MAT value considered for price calculation | 102.15 | (Rs. In Lakhs) | -- | -- | -- | -- | -- | -- | |||
| -- | -- | Sum of PTR per unit considered for price calculation | 4.91 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| -- | -- | Number of Packs considered | -- | 2.00 | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Ceiling Price | -- | -- | 2.45 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | -- | -- | 0.39 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | MRP (without local taxes) | -- | -- | 2.85 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction with compared to Highest Price | -- | 20.87% | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
S.O. 2861(E) dated 20.09.13 |
-- |
|||||||||||
| S.No. | Unique No. as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-- |
|||||||||||||
| -- | 21.4.3.1 | Pilocarpine Drops 2% | FDC | Pilocar | Pilocar Eye Drops | ML | 5 | ML | 39.62 | 22,187,000 | 96.7% | 7.92 | -- |
| -- | 21.4.3.1 | Pilocarpine Drops 2% | Sunways | Carpinol | Carpinol Eye Drop | ML | 5 | ML | 45.71 | 753,942 | 3.3% | 9.14 | -- |
| -- |
-- |
-- | -- | -- | 22,940,942 | 100% | 8.53 | 9.90 | |||||
| -- |
-- |
-- | -- | -- | maximum | 9.14 | minimum | 7.92 | |||||
| -- | -- |
-- |
-- | -- | -- | -- | -- | -- |
-- |
||||
| -- | -- | Sum of total value of MAT considered for price calculation | 229.41 | (Rs. In Lakhs) | -- | -- | -- | -- |
-- |
||||
| -- | -- | Number of Packs considered | -- | 2 | -- | -- | -- | -- | -- | -- |
-- |
||
| -- | -- | Sum of total value of Price per unit considered for price cal | 17.07 | -- | -- | -- | -- | -- | -- |
-- |
|||
| -- | -- | Ceiling Price |
-- |
8.53 | -- | -- | -- | -- | -- | -- |
-- |
||
| -- | -- | Add : 16% Retailer Margin |
-- |
1.37 | -- | -- | -- | -- | -- | -- |
-- |
||
| -- | -- | MRP (without local taxes) |
-- |
9.90 | -- | -- | -- | -- | -- | -- |
-- |
||
|
-- |
% Reduction with compared to Highest Price | -- | 6.66% |
-- |
|||||||||
|
-- |
S.O. 2862(E) dated 20.09.13 |
-- |
|||||||||||
| -- | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | -- |
| -- | 25.1.1.1 | Beclomethasone Dipropiona | Precept Pharma | Preflo-50 | Beclomethasone Dipropionate IP 50 mcg 1 x 1’s | Inhaler | 1 | Per In | 183.33 | 34200 | 100% | 183.33 | -- |
| -- |
-- |
-- |
-- | -- | -- | -- | -- | ||||||
|
-- |
34200 | 100% | 183.33 | -- | |||||||||
|
-- |
Average Price | 183.33 |
-- |
||||||||||
|
-- |
Price with 16% Ma | 212.66 |
-- |
||||||||||
| % reduction to the highest price | 0.00% |
-- |
|||||||||||
Thus, it is a monopoly case since there are less than 5 manufacturers & insignificant reduction is observed as compared to the highest priced pack
PTR per unit as per IMS Health data : NA
Prices fixed in the relevant sub -section is as follows:
25.1 Antiasthmatic medicines
| S.No. | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | |
|---|---|---|---|---|---|---|---|---|---|
| -- | 1 | Beclomethasone Dipropiona | P, S, T | Inhalation | 50 mcg/dose |
-- |
-- | -- | |
| -- | 2 | Beclomethasone Dipropionate | P, S, T | Inhalation | 250 mcg/dose | 1.52 | 1st meeting | 1690(E | 7.73 |
| -- | 3 | Hydrocortisone Sodium Succin | P, S, T | Injection | 100 mg | 37.13 | 5th meeting | 2233(E | 44.72 |
| -- | 4 | Hydrocortisone Sodium Succin | P, S, T | Injection | 200 mg | -- | -- | -- | -- |
| -- | 5 | Hydrocortisone Sodium Succin | P, S, T | Injection | 400 mg | 135.70 | 1st meeting | 1691(E | 8.62 |
| -- | 6 | Salbutamol Sulphate | P, S, T | Tablets | 2mg | DPCO, 1995 | -- | -- | |
| -- | 7 | Salbutamol Sulphate | P, S, T | Tablets | 4mg | DPCO, 19 | -- | -- | -- |
| -- | 8 | Salbutamol Sulphate | P, S, T | Syrup | 2mg/5ml | DPCO, 19 | -- | -- | -- |
| -- | 9 | Salbutamol Sulphate | P, S, T | Inhalation | 100 mcg/dose | DPCO, 19 | -- | -- | -- |
| -- | 10 | Ipratropium Bromide | P, S, T | Inhalation | 20mcg/metered Dose | -- | -- | -- | -- |
|
-- |
-- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Average Reduction |
-- |
-- |
-- | 20.36 | ||||
|
-- |
-- |
-- |
-- |
||||||
|
-- |
Therfore,per unit price as per Para 6(ii) of D | -- | 183.33*(1-20.36% | 146.01 | -- |
-- |
|||
|
-- |
Add margin 16% |
-- |
-- | 23.36 | -- |
-- |
|||
|
-- |
Ceiling Price |
-- |
-- | 169.37 | -- |
-- |
|||
|
-- |
S.O. 2846(E) dated 20.09.13 | -- | |||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 25.1.2.2 | Hydrocortisone Sodium Succin | Macleods | Primacort 200mg | Hydrocortisone Sodium Succinate BP equiv. to Hydrocortisone 200mg | Injection | 1 | Per ml | 77.34 | 27,241,000 | 100% | 77.34 |
| -- |
-- |
-- |
-- | -- | -- | -- | ||||||
|
-- |
27,241,000 | 100% | 77.34 | |||||||||
|
-- |
Average Price | 77.34 |
-- |
-- | -- | -- | ||||||
|
-- |
Price with 16% Ma | 89.71 |
-- |
-- | -- | -- | ||||||
|
-- |
% reduction to the highest price | 0.00% |
-- |
|||||||||
|
-- |
Thus, it is a monopoly case since there are less than 5 manufacturers & insignificant reduction is observed as compared to the highest priced pack |
-- |
||||||||||
| -- | PTR per unit as per IMS Health data | -- | NA |
-- |
-- |
|||||||
| -- | Prices fixed in the relevant sub -section is as follows: |
-- |
-- |
|||||||||
|
-- |
25.1 Antiasthmatic medicines |
-- |
||||||||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack |
-- |
|||
|
-- |
Beclomethasone Dipropionate | P, S, T | Inhalation | 50 mcg/dose |
-- |
-- | -- |
-- |
||||
|
-- |
Beclomethasone Dipropionate | P, S, T | Inhalation | 250 mcg/dose | 1.52 | 1st meeting | 1690(E) dt 14.06.2013 | 7.73 |
-- |
|||
|
-- |
Hydrocortisone Sodium Succin | P, S, T | Injection | 100 mg | 37.13 | 5th meeting | 2233(E) dt 22.07.2013 | 44.72 |
-- |
|||
| -- | -- | Hydrocortisone Sodium Suc | P, S, T | Injection | 200 mg | -- | -- | -- | -- |
-- |
-- | |
|
-- |
Hydrocortisone Sodium Succin | P, S, T | Injection | 400 mg | 135.70 | 1st meeting | 1691(E) dt 14.06.2013 | 8.62 | -- | -- | -- | |
|
-- |
Salbutamol Sulphate | P, S, T | Tablets | 2mg | DPCO, 1995 | -- | -- | -- | -- | -- | ||
|
-- |
Salbutamol Sulphate | P, S, T | Tablets | 4mg | DPCO, 19 | -- | -- | -- | -- | -- | -- | |
|
-- |
Salbutamol Sulphate | P, S, T | Syrup | 2mg/5ml | DPCO, 19 | -- | -- | -- | -- | -- | -- | |
|
-- |
Salbutamol Sulphate | P, S, T | Inhalation | 100 mcg/dose | DPCO, 19 | -- | -- | -- | -- | -- | -- | |
|
-- |
Ipratropium Bromide | P, S, T | Inhalation | 20mcg/metered Dose | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
Average Reduction |
-- |
-- |
-- | 20.36 | -- | -- | -- | ||||
|
-- |
-- |
-- |
-- |
-- | -- | -- | ||||||
|
-- |
Therfore,per unit price as per Para 6(ii) of D | -- | 77.34*(1-20.36%) | 61.60 | -- |
-- |
-- | -- | -- | |||
|
-- |
Add margin 16% |
-- |
-- | 9.86 | -- |
-- |
-- | -- | -- | |||
|
-- |
Ceiling Price |
-- |
-- | 71.45 | -- |
-- |
-- | -- | -- | |||
| -- |
-- |
S.O. 2847( |
-- |
-- | -- | -- | ||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 25.1.4.1 | Ipratropium bromide Inhalation 20μg/metered dose | CIPLA | IPRAVENT | IPRAVENT INHA | Aerosols | 200 | Aeroso | 146.15 | 12,116,324 | 99.95% | 0.73 |
| -- | 25.1.4.1 | Ipratropium bromide Inhalation 20μg/metered dose | ZYDUS CADILA* | IPRAMIST | IPRAMIST INHA | Aerosols | 200 | Aeroso | 121.42 | 6,435 | 0.05% | 0.61 |
|
-- |
12,122,759 | 100% | 0.73 | |||||||||
|
-- |
Average Price | 0.73 |
-- |
-- | -- | -- | ||||||
|
-- |
Price with 16% Ma | 0.85 |
-- |
-- | -- | -- | ||||||
|
-- |
% reduction to the highest price | 0.00% |
-- |
|||||||||
|
-- |
Thus, it is a monopoly case since there are less than 5 manufacturers & insignificant reduction is observed as compared to the highest priced pack |
-- |
||||||||||
| -- | PTR per unit as per IMS Health data | -- | Rs. 0.73 |
-- |
-- |
|||||||
| -- | Prices fixed in the relevant sub -section is as follows: |
-- |
-- |
|||||||||
|
-- |
25.1 Antiasthmatic medicines |
-- |
||||||||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack |
-- |
|||
|
-- |
Beclomethasone Dipropionate | P, S, T | Inhalation | 50 mcg/dose |
-- |
-- | -- |
-- |
||||
|
-- |
Beclomethasone Dipropionate | P, S, T | Inhalation | 250 mcg/dose | 1.52 | 1st meeting | 1690(E) dt 14.06.2013 | 7.73 |
-- |
|||
|
-- |
Hydrocortisone Sodium Succinate | P, S, T | Injection | 100 mg | 37.13 | 5th meeting | 2233(E) dt 22.07.2013 | 44.72 |
-- |
|||
|
-- |
Hydrocortisone Sodium Succinate | P, S, T | Injection | 200 mg | -- | -- | -- | -- |
-- |
|||
|
-- |
Hydrocortisone Sodium Succinate | P, S, T | Injection | 400 mg | 135.70 | 1st meeting | 1691(E) dt 14.06.2013 | 8.62 | -- |
-- |
||
|
-- |
Salbutamol Sulphate | P, S, T | Tablets | 2mg | DPCO, 1995 | -- | -- | -- |
-- |
|||
|
-- |
Salbutamol Sulphate | P, S, T | Tablets | 4mg | DPCO, 19 | -- | -- | -- | -- |
-- |
||
|
-- |
Salbutamol Sulphate | P, S, T | Syrup | 2mg/5ml | DPCO, 19 | -- | -- | -- | -- |
-- |
||
|
-- |
Salbutamol Sulphate | P, S, T | Inhalation | 100 mcg/dose | DPCO, 19 | -- | -- | -- | -- |
-- |
||
| -- | -- | Ipratropium Bromide | P, S, T | Inhalation | 20mcg/metered Dose |
-- |
-- | -- | -- |
-- |
||
|
-- |
-- | -- |
-- |
-- | -- | -- | -- | -- |
-- |
|||
|
-- |
Average Reduction |
-- |
-- |
-- | 20.36 | -- |
-- |
|||||
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||||
|
-- |
Therfore,per unit price as per Para 6(ii) of D | -- | 0.73*(1-20.36%) | 0.58 | -- |
-- |
-- |
-- |
||||
|
-- |
Add margin 16% |
-- |
-- | 0.09 | -- |
-- |
-- |
-- |
||||
|
-- |
Ceiling Price |
-- |
-- | 0.68 | -- |
-- |
-- |
-- |
||||
|
-- |
S.O. 2848(E) dated 20.09.13 |
-- |
||||||||||
| S.No. | Unique No. as per NLEM | NLEM Description | COMPANY | BRANDS | Pack Description | Pack size | Unit | Price to Retailer (PR) | MAT Value as on 31.05.2012 | MAT % | Price per unit (ML) | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Albert David | Ringer Lactate | Ringer Lactate S | 500 | ml | 31.89 | 116359884 | 3.71% | 0.06 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Albert David | Ringer Lactate | Ringer Lactate S | 1000 | ml | 41.29 | 32495918 | 1.03% | 0.04 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Baxter | Ringer Lactate | Ringer Lactate S | 500 | ml | 24.30 | 300878366 | 9.58% | 0.05 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Nirma Ltd | Ringer Lactate | Non-PVC Bags | 500 | ml | 55.62 | 521098 | 0.02% | 0.11 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Nirma Ltd | Ringer Lactate | FFS Plastic Bottl | 100 | ml | 14.45 | 1851102 | 0.06% | 0.14 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Nirma Ltd | Ringer Lactate | FFS Plastic Bottl | 250 | ml | 25.60 | 11717540 | 0.37% | 0.10 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Nirma Ltd | Ringer Lactate | FFS Plastic Bottl | 500 | ml | 45.60 | 1104566133 | 35.17% | 0.09 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Nirma Ltd | Ringer Lactate | FFS Plastic Bottl | 1000 | ml | 54.39 | 89267625 | 2.84% | 0.05 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Claris Lifescien | Lactated Ring | Lactated Ringer | 500 | ml | 59.27 | 911032472 | 29.01% | 0.12 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Claris Lifescien | Ringer Lactate | Ringer Lactate N | 500 | ml | 69.15 | 32060983 | 1.02% | 0.14 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Claris Lifescien | Ringer Lactate | Ringer Lactate Ni | 1000 | ml | 66.45 | 107373100 | 3.42% | 0.07 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Claris Lifescien | Ringer Lactate | Ringer Lactate N | 1000 | ml | 90.61 | 4084246 | 0.13% | 0.09 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Fresenius Kabi | Ringer Lactate | Ringer Lactate SO | 500 | ml | 23.34 | 26440745 | 0.84% | 0.05 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Krishnakeshav L | Ringer Lactate | Ringer Lactate SO | 250 | ml | 31.46 | 41899 | 0.00% | 0.13 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Krishnakeshav L | Ringer Lactate | Ringer Lactate SO | 500 | ml | 49.81 | 2575569 | 0.08% | 0.10 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Krishnakeshav L | Ringer Lactate | Ringer Lactate SO | 1000 | ml | 58.92 | 46864 | 0.00% | 0.06 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Mount Mettur | Ringer Lactate | Ringer Lactate SO | 500 | ml | 28.99 | 117120 | 0.00% | 0.06 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Parenteral Drugs | Ringer Lactate | Ringer Lactate INF | 500 | ml | 25.50 | 29213756 | 0.93% | 0.05 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Parenteral Drugs | Ringer Lactate | Ringer Lactate INF | 1000 | ml | 33.00 | 1338622 | 0.04% | 0.03 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Prem Pharma | Ringer Lactate | Ringer Lactate SO | 500 | ml | 26.00 | 1306376 | 0.04% | 0.05 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Wockhardt Ltd | Ringer Lactate | Ringer Lactate INF | 500 | ml | 28.00 | 4633706 | 0.15% | 0.06 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Abaris Healthcar | Ringer Lactate | Ringer Lactate Inje | 500 | ml | 65.72 | 9546850 | 0.30% | 0.13 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As per | Anghu Pharma P | Ringer Lactate | Ringer Lactate Inj I | 500 | ml | 22.08 | 982422 | 0.03% | 0.04 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Marck Bioscien | Ringer Lactate | Ringer Lactate Ni | 500 | ml | 59.19 | 248248178 | 7.90% | 0.12 | -- |
| -- | 26.2.7.1 | Ringer Lactate Injection As p | Marck Bioscien | Ringer Lactate | Ringer Lactate Ni | 1000 | ml | 77.56 | 103890212 | 3.31% | 0.08 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | 3140590785 | 100.00% | 2.02 | 0.10 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- |
-- |
-- | -- | -- | -- | -- | |||||
| -- | -- | Sum of MAT value considered for price calculation | 30643.47 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Sum of PTR per unit considered for price calculation | 1.27 | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | -- | 14 | -- | -- | -- | MAX | 0.14 | MIN | 0.04 | -- |
| -- | -- | Ceiling Price | -- | 0.09 | -- | -- | -- | -- | Avg. PTR | 0.09 | -- | -- |
| -- | -- | Add : 16% Retailer Margin | -- | 0.01 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | MRP (without local taxes) | -- | 0.10 | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction as compared to Highest Price | 37.36% | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
S.O. 2863(E) dated 20.09.13 |
-- |
||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.2.8.1 | Sodium Bicarbonate Inj (As p | Arco Lifescienc | NA | 10 ml Ampoule | Injection | 1 | Per A | 13.33 | 782554 | 8.73% | 1.33 | -- |
| -- | 26.2.8.1 | Sodium Bicarbonate Inj (As per | Ravi Pharmaceut | NA | 25 ml Ampoule | Injection | 1 | Per Am | 5.90 | 22420 | 0.25% | 0.24 | -- |
| -- | 26.2.8.1 | Sodium Bicarbonate Inj (As p | Neon Laborator | NA | 25 ml Ampoule | Injection | 1 | Per A | 21.50 | 8160000 | 91.02% | 0.86 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8964974 | 100.00% | 2.43 | 1.27 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- |
-- |
-- | -- | -- | -- | -- | -- | |||||
| -- | -- | Sum of MAT Value considered for price calculation | 89.43 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | -- | 2 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Sum of PTR per unit considered for price calculation | 2.19 | -- | -- | -- | -- | Max. | 1.33 | Min. | 0.86 | -- | |
| -- | -- | Average PTR | -- | 1.10 | -- | -- | -- | -- | -- | -- | Avg. PTR | 1.10 | -- |
| -- | -- | Add : 16% Retailer Margin | -- | 0.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Ceiling Price (without local ta | -- | 1.27 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction with compared to highest price | 17.74% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | -- | S.O. 2864(E) d | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.3.1.2 | Water For Injection (5ml) | Marck Bioscienc | NA | 5ml Nipple head-P | Inj. | 1 | Per Nip | 2.46 | 1371811 | 0.37% | 2.46 | -- |
| -- | 26.3.1.2 | Water For Injection (5ml) | Nirma Ltd. | NA | FFS Plastic amp. | Inj. | 1 | Per Ni | 3.08 | 366731531 | 97.94% | 3.08 | -- |
| -- | 26.3.1.2 | Water For Injection (5ml) | Claris Lifescien | NA | Plastic Ampoule | Inj. | 1 | Per Ni | 2.87 | 6357020 | 1.70% | 2.87 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 374460362 | 100.00% | 8.41 | 3.45 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | MAX | 3.08 | MIN | 2.87 | -- |
| -- | -- |
-- |
-- | -- | -- | Avg. PTR | 2.98 | -- | |||||
| -- | -- | Sum of MAT Value considered for price calculation | 3730.89 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | 2 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Sum of PTR per unit considered for price calculation | 5.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Average PTR | -- | 2.98 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | 0.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Ceiling Price (without local taxes) | 3.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | % Reduction with compared to highest price | 3.41% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | -- | S.O. 2865(E) d | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 26.3.1.3 | Water For Injection (10ml) | Marck Bioscien | NA | Nipple head-Plas | -- | 1 | Per Ni | 4.51 | 12347989 | 2.18% | 4.51 | -- |
| -- | 26.3.1.3 | Water For Injection (10ml) | Nirma Ltd. | NA | FFS Plastic amp. | -- | 1 | Per Ni | 4.10 | 530706228 | 93.82% | 4.10 | -- |
| -- | 26.3.1.3 | Water For Injection (10ml) | Claris Lifescien | NA | Plastic Ampoule | -- | 1 | Per Ni | 3.70 | 22610220 | 4.00% | 3.70 | 4.76 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 565664437 | 100.00% | 12.31 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | MAX. | 4.51 | MIN. | 3.70 | -- |
| -- | -- |
-- |
-- | -- | -- | Avg. PTR | 4.10 | -- | |||||
| -- | -- | Sum of MAT Value considered for price calculation | 5656.64 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | -- | 3 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Sum of PTR per unit considered for price calculation | 12.31 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Average PTR | -- | 4.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | -- | 0.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Ceiling Price (without local ta | -- | 4.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction with compared to highest price | 9.02% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | -- | S.O. 2866(E) d | -- | -- | -- | -- | -- | -- | -- | -- | |
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 30 | Per Ta | 53.40 | 13643178 | ########### | 1.78 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 60 | Per Ta | 83.97 | 13137968 | ########### | 1.40 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 100 | Per Ta | 117.51 | 17829618 | ########### | 1.18 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 30 | Per Ta | 53.40 | 21267634 | ########### | 1.78 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 60 | Per Ta | 83.97 | 15590484 | ########### | 1.40 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 2 | Novartis Intl.* | Calcium Sand | Calcium Sandoz | Tablets | 100 | Per Ta | 117.49 | 24166656 | ########### | 1.17 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | RANBAXY* | CALZAC | CALZAC TABS C | Tablets | 30 | Per Ta | 22.19 | 249638 | 611914.09% | 0.74 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | RANBAXY* | CALZAC | CALZAC TAB CH | Tablets | 60 | Per Ta | 32.00 | 475905 | 1166541.04% | 0.53 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | RANBAXY* | CALZAC | CALZAC TABS C | Tablets | 60 | Per Ta | 29.59 | 100340 | 245953.98% | 0.49 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | GRAF LABS | G-CAL | G-CAL TABS 250 | Tablets | 10 | Per Ta | 8.98 | 102533 | 251329.47% | 0.90 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | RELIANCE | OSTIGEN | OSTIGEN TABS 2 | Tablets | 10 | Per Ta | 9.45 | 11557 | 28328.58% | 0.95 | -- |
| -- | 27.0.2.1 | Calcium carbonate Tablets 250 | STEDMAN | M-CAL | M-CAL TABS 250 | Tablets | 10 | Per Ta | 12.25 | 2548 | 6245.67% | 1.22 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 106578059 | ########### | 13.54 | 1.68 |
| -- | -- | Sum of MAT Value considered for price calculation | 1056.36 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | -- | 6 | -- | -- | -- | MAX | 1.78 | MIN | 1.17 | -- | -- |
| -- | -- | Sum of PTR per unit considered for price calculation | 8.71 | -- | -- | -- | -- | Avg. PTR | 1.45 | -- | -- | -- | |
| -- | -- | Average PTR | -- | 1.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Add : 16% Retailer Margin | -- | 0.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Ceiling Price (without local ta | -- | 1.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction as compared to highest price | 18.45% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
|
-- |
-- |
S.O. 2867(E) dated 20.09.13 | |||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 27.0.10.1 | Calcium Gluconate (100mg/ | Arco Lifescienc | NA | 10 ml Amp | Injection | 1 | Per A | 13.33 | 1174112 | 96.85% | 13.33 | -- |
| -- | 27.0.10.1 | Calcium Gluconate (100mg/ | Ravi Pharmace | Calcium Placi | 10 ml Amp | Injection | 1 | Per A | 3.82 | 38200 | 3.15% | 3.82 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1212312 | 100.00% | 17.15 | 9.95 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- |
-- |
-- | -- | -- | -- | -- | -- | |||||
| -- | -- | Sum of MAT Value considered for price calculation | 12.12 | (Rs. in lakh) | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | Number of Packs considered | -- | 2 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Sum of PTR per unit considered for price calculation | 17.15 | -- | -- | -- | -- | MAX | 13.33 | MIN | 3.82 | -- | |
| -- | -- | Average PTR | -- | 8.58 | -- | -- | -- | -- | -- | -- | Avg. PTR | 8.58 | -- |
| -- | -- | Add : 16% Retailer Margin | -- | 1.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | Ceiling Price (without local ta | -- | 9.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | % Reduction with compared to highest price | 35.67% | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| -- | -- | -- | -- | S.O. 2868(E) d | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| USN | NLEM | BRANDS | COMPANY | PACK_DESC | Dosage | Strength | Pack Size | PTR May | PTR per unit | May Mat 12 | MAT % | -- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1.2 | Diclofenac Inj | VOVERAN | NOVARTIS INTL.* | VOVERAN INJ IM. A | Inj | 75 | 3 | 13.01 | 4.34 | 559425506 | 52.10% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFAM | ABBOTT* | DICLOFAM INJ IM. A | Inj | 25 | 30 | 6.74 | 0.22 | 849298 | 0.08% | -- |
| 2.1.2. | Diclofenac Inje | ESGIPYRIN-DS | ABBOTT* | ESGIPYRIN-DS INJ I | Inj | 25 | 3 | 6.42 | 2.14 | 12354938 | 1.15% | -- |
| 2.1.2. | Diclofenac Inje | TOPAC | ABBOTT* | TOPAC INJ IM. AMP | Inj | 25 | 30 | 33.90 | 1.13 | 8966423 | 0.84% | -- |
| 2.1.2. | Diclofenac Inje | TOPAC | ABBOTT* | TOPAC INJ IM. AMP | Inj | 25 | 3 | 6.09 | 2.03 | 15949045 | 1.49% | -- |
| 2.1.2. | Diclofenac Inje | ZOBID | ABBOTT* | ZOBID INJ IM. AMP | Inj | 25 | 3 | 10.63 | 3.54 | 46914357 | 4.37% | -- |
| 2.1.2. | Diclofenac Inje | ZOBID | ABBOTT* | ZOBID INJ IM. VIAL | Inj | 25 | 30 | 33.68 | 1.12 | 28741434 | 2.68% | -- |
| 2.1.2. | Diclofenac Inje | DYNAPAR AQ | TROIKAA PHARMA | DYNAPAR AQ INJ IM | Inj | 25 | 30 | 33.53 | 1.12 | 16531057 | 1.54% | -- |
| 2.1.2. | Diclofenac Inje | DILONA | MAPRA LABS | DILONA INJ IM. AMP | Inj | 25 | 3 | 11.28 | 3.76 | 46958408 | 4.37% | -- |
| 2.1.2. | Diclofenac Inje | DICLOTAL | BLUE CROSS | DICLOTAL INJ VIAL | Inj | 25 | 30 | 10.00 | 0.33 | 16102391 | 1.50% | -- |
| 2.1.2. | Diclofenac Inje | DICLOTAL | BLUE CROSS | DICLOTAL INJ IM. A | Inj | 25 | 3 | 8.00 | 2.67 | 28954025 | 2.70% | -- |
| 2.1.2. | Diclofenac Inje | DEFENAC | LUPIN LIMITED | DEFENAC INJ IM. VI | Inj | 25 | 30 | 8.00 | 0.27 | 14237280 | 1.33% | -- |
| 2.1.2. | Diclofenac Inje | DEFENAC | LUPIN LIMITED | DEFENAC INJ IM. A | Inj | 25 | 3 | 1.77 | 0.59 | 5551462 | 0.52% | -- |
| 2.1.2. | Diclofenac Inje | DICLONAC | LUPIN LIMITED | DICLONAC INJ IM. A | Inj | 25 | 3 | 5.54 | 1.85 | 12071696 | 1.12% | -- |
| 2.1.2. | Diclofenac Inje | DICLONAC | LUPIN LIMITED | DICLONAC INJ IM. V | Inj | 25 | 150 | 182.50 | 1.22 | 1142711 | 0.11% | -- |
| 2.1.2. | Diclofenac Inje | DICLONAC | LUPIN LIMITED | DICLONAC INJ IM. V | Inj | 25 | 15 | 18.25 | 1.22 | 12829020 | 1.19% | -- |
| 2.1.2. | Diclofenac Inje | DICLONOVA | LUPIN LIMITED | DICLONOVA INJ AM | Inj | 25 | 3 | 2.00 | 0.67 | 770657 | 0.07% | -- |
| 2.1.2. | Diclofenac Inje | ACTIVA | ZYDUS CADILA* | ACTIVA INJ IM. AMP | Inj | 25 | 3 | 1.84 | 0.61 | 8032224 | 0.75% | -- |
| 2.1.2. | Diclofenac Inje | ACTIVA | ZYDUS CADILA* | ACTIVA INJ IM. VIA | Inj | 25 | 30 | 6.70 | 0.22 | 438112 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFEN | ZYDUS CADILA* | DICLOFEN INJ IM. A | Inj | 25 | 3 | 1.65 | 0.55 | 2132529 | 0.20% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFEN | ZYDUS CADILA* | DICLOFEN INJ IM. A | Inj | 25 | 30 | 5.50 | 0.18 | 1129637 | 0.11% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFENIC | ZYDUS CADILA* | DICLOFENIC INJ IM. | Inj | 25 | 30 | 8.80 | 0.29 | 38842 | 0.00% | -- |
| 2.1.2. | Diclofenac Inje | INAC | ZYDUS CADILA* | INAC INJ IM. AMP 2 | Inj | 25 | 3 | 7.32 | 2.44 | 15706991 | 1.46% | -- |
| 2.1.2. | Diclofenac Inje | JONAC | ZYDUS CADILA* | JONAC INJ IM. AMP | Inj | 75 | 3 | 4.61 | 1.54 | 16493686 | 1.54% | -- |
| 2.1.2. | Diclofenac Inje | VOVCAD | ZYDUS CADILA* | VOVCAD INJ AMP 25 | Inj | 25 | 3 | 1.71 | 0.57 | 18944 | 0.00% | -- |
| 2.1.2. | Diclofenac Inje | ZYDICLO | ZYDUS CADILA* | ZYDICLO INJ IM. AM | Inj | 25 | 3 | 1.76 | 0.59 | 476648 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | FENAK | RANBAXY* | FENAK INJ AMP 25 | Inj | 25 | 3 | 2.75 | 0.92 | 11517556 | 1.07% | -- |
| 2.1.2. | Diclofenac Inje | FENAK | RANBAXY* | FENAK INJ IM. VIAL | Inj | 25 | 30 | 8.54 | 0.28 | 34444997 | 3.21% | -- |
| 2.1.2. | Diclofenac Inje | OSTEOFLAM | INDOCO* | OSTEOFLAM INJ IM. | Inj | 25 | 30 | 25.74 | 0.86 | 6775324 | 0.63% | -- |
| 2.1.2. | Diclofenac Inje | OSTEOFLAM | INDOCO* | OSTEOFLAM INJ IM. | Inj | 25 | 3 | 3.66 | 1.22 | 7042042 | 0.66% | -- |
| 2.1.2. | Diclofenac Inje | DICLOMOL | WIN MEDICARE | DICLOMOL INJ IM. A | Inj | 25 | 3 | 7.28 | 2.43 | 5041357 | 0.47% | -- |
| 2.1.2. | Diclofenac Inje | DICLOMOL | WIN MEDICARE | DICLOMOL INJ IM. A | Inj | 25 | 30 | 72.76 | 2.43 | 297271 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | DICLOLAB | LABORATE PHARMA | DICLOLAB INJ IM. A | Inj | 25 | 3 | 1.50 | 0.50 | 1100322 | 0.10% | -- |
| 2.1.2. | Diclofenac Inje | DICLOLAB | LABORATE PHARMA | DICLOLAB INJ IM. VI | Inj | 25 | 30 | 5.25 | 0.18 | 13485072 | 1.26% | -- |
| 2.1.2. | Diclofenac Inje | DICLORAN | UNIQUE PHARM | DICLORAN INJ AMP | Inj | 25 | 3 | 9.42 | 3.14 | 11249244 | 1.05% | -- |
| 2.1.2. | Diclofenac Inje | VALFEN | WOCKHARDT LTD* | VALFEN INJ IM. VIA | Inj | 25 | 30 | 7.19 | 0.24 | 6992672 | 0.65% | -- |
| 2.1.2. | Diclofenac Inje | VALFEN | WOCKHARDT LTD* | VALFEN INJ IM. AMP | Inj | 25 | 3 | 1.98 | 0.66 | 991994 | 0.09% | -- |
| 2.1.2. | Diclofenac Inje | DICLOMAX | TORRENT PHARMA | DICLOMAX INJ IM. A | Inj | 25 | 3 | 8.44 | 2.81 | 4910274 | 0.46% | -- |
| 2.1.2. | Diclofenac Inje | DICLOMAX | TORRENT PHARMA | DICLOMAX INJ IM. V | Inj | 25 | 30 | 24.83 | 0.83 | 3728170 | 0.35% | -- |
| 2.1.2. | Diclofenac Inje | DOLOBAN | MANKIND | DOLOBAN INJ IM. A | Inj | 25 | 3 | 8.00 | 2.67 | 6742030 | 0.63% | -- |
| 2.1.2. | Diclofenac Inje | JUSTIN | NEON LABS | JUSTIN INJ AMP 25 | Inj | 25 | 3 | 4.28 | 1.43 | 8109976 | 0.76% | -- |
| 2.1.2. | Diclofenac Inje | TROMAX | ARISTO PHARMA* | TROMAX INJ IM. AM | Inj | 75 | 3 | 4.27 | 1.42 | 5576876 | 0.52% | -- |
| 2.1.2. | Diclofenac Inje | BESTODEK | BESTOCHEM | BESTODEK INJ AMP | Inj | 25 | 3 | 9.96 | 3.32 | 3852851 | 0.36% | -- |
| 2.1.2. | Diclofenac Inje | VIVOGESIC | BESTOCHEM | VIVOGESIC INJ IM. | Inj | 25 | 3 | 7.24 | 2.41 | 4395749 | 0.41% | -- |
| 2.1.2. | Diclofenac Inje | DILOFEN | P B LABS | DILOFEN INJ IM. AM | Inj | 25 | 3 | 6.60 | 2.20 | 2321009 | 0.22% | -- |
| 2.1.2. | Diclofenac Inje | DILOFEN | P B LABS | DILOFEN INJ IM. VI | Inj | 25 | 15 | 14.04 | 0.94 | 3126109 | 0.29% | -- |
| 2.1.2. | Diclofenac Inje | ADIFLAM | LEBEN LABS | ADIFLAM INJ IM. VI | Inj | 25 | 30 | 16.32 | 0.54 | 4335024 | 0.40% | -- |
| 2.1.2. | Diclofenac Inje | ADIFLAM | LEBEN LABS | ADIFLAM INJ VIAL 2 | Inj | 25 | 3 | 4.66 | 1.55 | 368352 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | DIVON | MICRO LABS* | DIVON INJ IM. AMP | Inj | 25 | 3 | 8.45 | 2.82 | 7630831 | 0.71% | -- |
| 2.1.2. | Diclofenac Inje | NUFENAC | KARNATAKA ANTIBIOT | NUFENAC INJ AMP 7 | Inj | 75 | 3 | 5.00 | 1.67 | 3901236 | 0.36% | -- |
| 2.1.2. | Diclofenac Inje | DOFEC | DWD PHARMACEUTIC | DOFEC INJ AMP 25 | Inj | 25 | 3 | 7.67 | 2.56 | 494204 | 0.05% | -- |
| 2.1.2. | Diclofenac Inje | DOFEC | DWD PHARMACEUTIC | DOFEC INJ VIAL 25 | Inj | 25 | 15 | 15.45 | 1.03 | 2939001 | 0.27% | -- |
| 2.1.2. | Diclofenac Inje | NAC | SYSTOPIC | NAC INJ IM. AMP 25 | Inj | 25 | 3 | 6.10 | 2.03 | 5956450 | 0.55% | -- |
| 2.1.2. | Diclofenac Inje | NAC | SYSTOPIC | NAC INJ IM. AMP 25 | Inj | 25 | 15 | 30.50 | 2.03 | 472594 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFLAME | INTAS PHARMA* | DICLOFLAME INJ IM. | Inj | 25 | 30 | 6.96 | 0.23 | 2162957 | 0.20% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFLAME | INTAS PHARMA* | DICLOFLAME INJ IM. | Inj | 25 | 3 | 1.70 | 0.57 | 2613381 | 0.24% | -- |
| 2.1.2. | Diclofenac Inje | VOLFLAM | PSYCHOTROPICS | VOLFLAM INJ AMP 2 | Inj | 25 | 3 | 4.60 | 1.53 | 1730949 | 0.16% | -- |
| 2.1.2. | Diclofenac Inje | PAIN-OFF | MERCURY LABS | PAIN-OFF INJ AMP | Inj | 25 | 3 | 5.48 | 1.83 | 2673646 | 0.25% | -- |
| 2.1.2. | Diclofenac Inje | VIVIAN | LINCOLN PHARMA | VIVIAN INJ IM. AMP | Inj | 25 | 3 | 10.74 | 3.58 | 7781596 | 0.72% | -- |
| 2.1.2. | Diclofenac Inje | POWERFLAM | ALKEM* | POWERFLAM INJ VI | Inj | 25 | 3 | 1.93 | 0.64 | 844513 | 0.08% | -- |
| 2.1.2. | Diclofenac Inje | ELDOFEN | ELDER PHARMA | ELDOFEN INJ AMP 2 | Inj | 25 | 3 | 1.98 | 0.66 | 392003 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | ELDOFEN | ELDER PHARMA | ELDOFEN INJ VIAL 2 | Inj | 25 | 30 | 22.53 | 0.75 | 549734 | 0.05% | -- |
| 2.1.2. | Diclofenac Inje | ONTAC | ELDER PHARMA | ONTAC INJ IM. VIAL | Inj | 25 | 3 | 7.19 | 2.40 | 4952635 | 0.46% | -- |
| 2.1.2. | Diclofenac Inje | VOVO | ALEMBIC | VOVO INJ IM. VIAL | Inj | 25 | 30 | 8.40 | 0.28 | 1158304 | 0.11% | -- |
| 2.1.2. | Diclofenac Inje | EXFLAM | MERCK LIMITED | EXFLAM INJ IM. AM | Inj | 25 | 3 | 4.87 | 1.62 | 1357110 | 0.13% | -- |
| 2.1.2. | Diclofenac Inje | DICLOFAM | MAX INDIA | DICLOFAM INJ IM. A | Inj | 25 | 3 | 1.40 | 0.47 | 355951 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | XEROFLAM | HELIOS | XEROFLAM INJ AMP | Inj | 25 | 3 | 6.44 | 2.15 | 937502 | 0.09% | -- |
| 2.1.2. | Diclofenac Inje | AGILE | IND-SWIFT | AGILE INJ IM. AMP | Inj | 25 | 30 | 73.50 | 2.45 | 414622 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | AGILE | IND-SWIFT | AGILE INJ IM. AMP | Inj | 25 | 3 | 7.35 | 2.45 | 387788 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | DICOLIV | IND-SWIFT | DICOLIV INJ IM. VIA | Inj | 25 | 30 | 6.38 | 0.21 | 99127 | 0.01% | -- |
| 2.1.2. | Diclofenac Inje | DICLOGEN | AGIO PHARMA | DICLOGEN INJ AMP | Inj | 75 | 3 | 8.38 | 2.79 | 2140053 | 0.20% | -- |
| 2.1.2. | Diclofenac Inje | DOFLEX | JAGSON PAL | DOFLEX INJ IM. VIA | Inj | 25 | 30 | 7.60 | 0.25 | 421199 | 0.04% | -- |
| 2.1.2. | Diclofenac Inje | LIPCY | COMED CHEMICALS | LIPCY INJ IM. AMP | Inj | 25 | 3 | 3.78 | 1.26 | 353282 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | VOLIGESIC | RPG LIFE SCIENCES | VOLIGESIC INJ AMP | Inj | 25 | 3 | 1.71 | 0.57 | 222371 | 0.02% | -- |
| 2.1.2. | Diclofenac Inje | DICLOSTAR | CADILA PHARMA | DICLOSTAR INJ IM. | Inj | 25 | 3 | 5.90 | 1.97 | 329938 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | ALKORAN | BLISS | ALKORAN INJ IM. VI | Inj | 25 | 30 | 7.00 | 0.23 | 18569 | 0.00% | -- |
| 2.1.2. | Diclofenac Inje | FENAC | CLARIS LIFESCIENCE | FENAC INJ AMP 75 | Inj | 75 | 3 | 1.80 | 0.60 | 234133 | 0.02% | -- |
| 2.1.2. | Diclofenac Inje | KLOFEN | UNICHEM* | KLOFEN INJ IM. VIA | Inj | 25 | 30 | 8.25 | 0.28 | 274533 | 0.03% | -- |
| 2.1.2. | Diclofenac Inje | DICRON | KAMRON | DICRON INJ IM. AMP | Inj | 25 | 3 | 5.29 | 1.76 | 261204 | 0.02% | -- |
| 2.1.2. | Diclofenac Inje | DYKAY | REMEDIES | DYKAY INJ IM. AMP | Inj | 75 | 3 | 12.10 | 4.03 | 122149 | 0.01% | -- |
| 2.1.2. | Diclofenac Inje | GLYGESIC | TORQUE PHARMA | GLYGESIC INJ AMP | Inj | 25 | 3 | 1.90 | 0.63 | 97804 | 0.01% | -- |
| 2.1.2. | Diclofenac Inje | PARAFORTAN | KHANDELWAL | PARAFORTAN INJ A | Inj | 25 | 3 | 5.52 | 1.84 | 8905 | 0.00% | -- |
| 2.1.2. | Diclofenac Inje | DICLO | NATCO PHARMA | DICLO INJ IM. VIAL | Inj | 25 | 30 | 9.00 | 0.30 | 73044 | 0.01% | -- |
| 2.1.2. | Diclofenac Inje | FENCURE | BIO ETHICALS | FENCURE INJ IM. A | Inj | 25 | 3 | 7.00 | 2.33 | 79870 | 0.01% | -- |
|
-- |
-- | -- | -- | 1.28 | 1073664780 | 100.00% | 1.49 | |||||
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 4.34 | minimum | 0.18 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of MAT val | -- | -- | -- | -- | 9584.32 | (Rs. In Lakhs) | -- | -- | -- | -- | -- |
| -- | Sum of PTR per | -- | -- | -- | -- | 42.3 | -- | -- | -- | -- | -- | -- |
| -- | Number of Pac | -- | -- | -- | -- | 33 | -- | -- | -- | -- | -- | -- |
| -- | Ceiling Price | -- | -- | -- | -- | 1.28 | -- | -- | -- | -- | -- | -- |
| -- | Add : 16% Retai | -- | -- | -- | -- | 0.21 | -- | -- | -- | -- | -- | -- |
| -- | MRP (without lo | -- | -- | -- | -- | 1.49 | -- |
-- |
-- |
|||
| -- | % Reduction wi | -- | -- | -- | -- | 70.44% | -- |
-- |
-- |
|||
|
-- |
S.O. 2869(E) dated 20.09.13 | |||||||||||
[1]
NPPA:
Mat value not given because product mfr. From May 2012
Last Page Updated: 24-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)